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Summary of Thesis 
 
This thesis investigates the development of a MEMS (microelectromechanical system) 
device which can be implanted in the eye to continuously monitor glaucoma conditions. 
The thesis commences with a brief introduction to glaucoma and the problems 
associated with current treatment methods. A mathematical model of the intraocular 
pressure (IOP) dynamics of the eye is then used to analyse how IOP measurements 
could be utilised to internally indicate a change in the level of severity of glaucoma 
using a MEMS device. Finite element method analyses are then used to determine the 
electro-mechanical requirements of a MEMS pressure sensor that would be capable of 
continuously monitoring glaucoma from within the eye.  The results from both the 
investigations are then combined mathematically in a model to estimate the electronic 
response that would be obtained from an implantable micro system comprising a 
MEMS device to increase the pressure within the eye, a pressure sensor and processing 
electronics. The mathematical model of the micro system was tested for normal and 
adverse operating conditions to estimate the output corresponding to various levels of 
IOP in a person’s eye. An overview of the powering, fabrication, biocompatibility and 
packaging details of the MEMS glaucoma monitoring system has also been provided in 
the thesis. Finally, it is concluded that it will be possible to monitor glaucoma 
continuously from within the eye using a MEMS device. 
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ABSTRACT 
 
The objective of this thesis was to investigate the development of 
microelectromechanical system (MEMS) which can be implanted in the eye to provide 
continuous monitoring of glaucoma conditions. Current glaucoma monitoring involves 
taking laboratory based intra ocular pressure (IOP) measurements. The measurement of 
intraocular fluid flow and IOP parameters related to blockage formation in the eye 
require to be continuously monitored in Glaucoma. Making blockage related 
information available to patients could indicate the conditions leading to a blockage and 
help to improve glaucoma treatment and reduce the risk of permanent blindness.  
 
The specific aim of this research was to develop an implantable micro device capable of 
responding to the blockage of fluid flow in the eye. A mathematical model of the IOP 
dynamics in the eye, incorporating the IOP exponential decay phenomenon, was used to 
study the pressure changes that will occur in the eye due to glaucoma during external 
measurements. The mathematical model helped to analyse the principle behind IOP 
measurement and was extended to internal measurements by analysing time-based 
changes of variables integral to the process, such as eye rigidity, size, pressure, volume 
etc. The mathematical simulations helped to determine the physical requirements of an 
implantable micro device capable of increasing the IOP temporarily for the duration of a 
measurement. Finite element method analyses were conducted to determine the 
dimensions of a MEMS pressure sensor that could respond mechanically to the pressure 
changes initiated inside the eye by the micro device and convert the responses to 
electrically measurable units. The pressure resolution required of the MEMS pressure 
sensor was learned from the investigations and the electrical output indicative of the 
extent of glaucoma in an eye was also calculated. 
 
Integrating the intraocular dynamics and the MEMS pressure sensor responses 
constituted a mathematical model of the implantable micro system. The micro system 
model was tested for normal and adverse eye operating conditions to estimate the output 
based on various internal IOP measurements. The output that would be obtained from 
the implantable micro system was compared to responses from external measurements 
and found to be comparable. An overview of a comprehensive MEMS monitoring 
 vi 
system including the micro device to increase the pressure within the eye, a MEMS 
pressure sensor, and powering and signal conditioning electronics was provided. A 
description of the technologies that could be used for the fabrication and packaging of 
the device and the sensor was also included at the end of the thesis along with a 
discussion on bio-compatibility and implanting issues. 
  
Thus the feasibility of combining a micro device and a micro sensor with powering and 
signal conditioning electronics to create an implantable MEMS system that can make 
continuous measurements which can indicate the onset of or an increase in blockage of 
the eye of a person with glaucoma is presented in the thesis. 
 
A paper titled “A MEMS Glaucoma Monitoring Device” has been published in the 
International Society for Optical Engineering (SPIE) Journal and a poster paper was 
presented at the SPIE International Symposium for Micro and Nano Materials held at 
the University of Technology in Sydney, December 11-15, 2004.  
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1 Introduction 
 
 
1.1 Motivation 
 
It has been estimated that at least 65 million people worldwide are affected by 
glaucoma. Of this number, at least 3 million people are permanently blind [1]. 
Glaucoma has been recorded in literature to be the third leading cause of irreversible 
blindness in adults [2].  The risk of going blind from the disease is more likely in 
developing countries in comparison to developed countries [3].  It has been recorded 
adults over 40 with a history of heart disease, diabetes or a family history of eye 
disease, run a higher risk of developing glaucoma and therefore the ageing population of 
a country generally forms the target group for this disease [4]. Glaucoma is also known 
to occur as a congenital condition [5].  
 
The major symptoms of glaucoma are elevated intra ocular pressure (IOP), optic disc 
cupping, optic nerve damage and visual field loss [6].  The disease occurs when the 
drainage of fluid (aqueous humor) that flows continuously within the eye is obstructed. 
Fluid flow obstruction causes IOP to rise. An increase in IOP is associated with 
destruction of the optic nerve and is responsible for the occurrence of irreversible vision 
loss in human beings [7]. There is no cure for this pathological condition, however, it 
can be controlled upon detection of onset and managed by life-long monitoring of 
symptoms using pharmacologic agents [8].  
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While monitoring and control of elevated IOP is the widely adopted method of treating 
glaucoma, there have been records of the disease progressing under normal IOP levels 
as in the case of normal tension glaucoma [9].  The deterioration of the condition is not 
noticeable until a sudden significant vision loss is reported, or a progressive worsening 
of the symptoms is observed. The loss of vision is not accompanied by pain or 
discomfort and there is the risk of the condition deteriorating even when being treated, 
unless frequent and timely monitoring of IOP and its symptoms is performed [10].  
 
As current monitoring methods do not allow for any indication of onset or progression 
of the disease, patients are exposed to the threat of permanent blindness while under 
clinical management. Therefore despite the treatment and monitoring methods made 
available to glaucoma patients, there are risks associated, as disease progression cannot 
be monitored in all cases. Indicating to the patient at an early stage about impending 
vision loss would make possible the necessary corrective action and has led to the 
investigations outlined in this thesis. 
 
 
1.2 Problems with monitoring Glaucoma 
 
Monitoring the progression of glaucoma is complicated because the measurement 
involves detecting a change in the delicate flow-IOP equilibrium inside the eye [11]. 
Due to the constant change and fluctuation of flow and pressure parameters, it is 
difficult to continuously measure and track the parameters that contribute to the 
progression of the disease. It is not possible to detect the changes immediately as they 
develop over a period of time [12]. 
 
1.2.1 Description of the eye  
 
In the eye, a fluid called aqueous humor is produced continuously by the ciliary bodies 
of the eye and flows into a hemispherical chamber called the anterior chamber, through 
the pupil [13].  As depicted in Figure 1.1, the cornea at the front and the iris at the back 
bind the anterior chamber. The clear aqueous humor fluid flows into the anterior 
chamber at the rate of approximately 2.5µl/min and fills up the 250 µl volume of the 
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anterior chamber [14]. The extremely slow flow rate of the fluid is suited to the 
lubrication and nourishment of the intraocular contents. The flow rate also maintains the 
IOP whose stability is vital for the preservation of the shape and rigidity of the eyeball. 
IOP is closely linked with the fluid flow rates and is also defined as the tissue pressure 
of the ocular contents [13]. 
 
 
               
F in 
F out 
 
Figure 1.1 An Illustration of the structures of the eye [15] 
 
The flow rate of aqueous humor into and out of the eye is balanced so that a stable IOP 
is maintained inside the eye. At equilibrium flow and pressure conditions an average 
IOP between 12-15mmHg is normally maintained in an eye [13].  
 
The fluid circulates within the anterior chamber and then exits through an annular 
opening running along the junction of the iris and sclera called Schlemm’s Canal, into a 
region that is made of tissue and is porous, known as the trabecular meshwork. 
Approximately 98% of the aqueous humor flows out through the annular opening into 
the trabecular meshwork and drains back into the circulatory system of the eye [16].  As 
the outflow of fluid occurs in a direction against gravity, most of the resistance to 
drainage is encountered at the outlet channels in the porous trabecular region of the eye 
[16].  
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 1.2.2 How glaucoma affects the eye 
 
When there is a resistance at the outlet regions, fluid flow is blocked and the flow-IOP 
equilibrium is altered [17]. Figure 1.2 below illustrates the regions at the fluid outlet 
where majority of the blockage occurs.  
 
 
                              
             
 Block 
 
Figure 1.2 An Illustration of the fluid outflow path from the eye [15] 
 
 
Some of the possible changes that could occur in the outlet region are: [18] 
 
1. The lens blocking the fluid inlet region. 
2. A rise in pressure at the exit regions. 
3. A part of the lens-iris dislocating or contracting thus blocking the 
angle of drainage. 
4. The cornea enlarging or expanding and thus blocking drainage.  
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The changes in the eye that prompt the blockage of fluid are known not to occur 
suddenly but accumulate gradually over a period of time. When a blockage occurs, IOP 
rises from 15 to nearly 25 mmHg. In severe cases, IOP has been recorded up to 40 
mmHg and above [18].  
 
1.2.3 Treatment of glaucoma 
 
 Doctors treating glaucoma target controlling IOP rise and maintenance of IOP within 
12-15 mmHg as a means of achieving proper flow regulation [19].IOP is measured 
externally on a monthly basis using a tonometer in a clinic [20]. The condition is treated 
with a pharmacologic known as beta-blockers or adrenergic agnostics which are used to 
clear blockages by regulating fluid production, inlet and exit pressures to maintain an 
optimal IOP level [21]. IOP is prone to fluctuations and has been recorded to vary 
during different times of the day [22]. When chemicals fail to bring down IOP, 
treatment is then focused on surgical removal and correction of the structures blocking 
fluid drainage [18]. 
 
Apart from raised IOP, patients with glaucoma have been observed to have an increased 
resistance to outflow of the aqueous humor which is also expressed as facility of 
outflow and is an important blockage related parameter denoted by the symbol Cf. The 
measurement of Cf levels is linked with the detection of the onset of a blockage as they 
could provide a direct indication of the level of resistance to flow [23]. The value of Cf 
is recorded during a type of IOP measurement known as tonography, but despite its 
potential to reveal greater clinical information regarding the progression of the disease, 
it has been restricted to research purposes in recent years [24]. 
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 1.3 Objective of this work 
 
The objective of this research is to investigate and develop a microelectromechanical 
system (MEMS) that can provide an indication of blockage onset in glaucoma by 
monitoring continuously factors that contribute to a rise in IOP. 
 
In recent times, microelectromechanical systems (MEMS) technology has shown the 
potential to allow for the development of Microsystems with the capacity and efficiency 
required for in-situ monitoring of biological phenomenon [25]. Over the last couple of 
decades, several developments utilising this technology have been reported in the 
automotive, defence, industrial and medical instrumentation sectors [26]. For example, 
lab-on-chip systems, micro-total analysis systems (μ-TAS), micro-sensors, micro-
actuators, micro-valves, micro-pumps, micro-dispensing units and diffuser pumps etc 
have been some of the recent additions to the micro system product family that find 
critical applications in the bio-medical research and development field [27].  
 
Micro pressure sensors for monitoring pressure activity in the human body, micro 
surgical tools, grippers, tweezers for minimally invasive surgery and micro fluid 
dispensing units follow in the large list of some of the examples of MEMS products 
currently in use [28], [29].  
 
These systems can be manufactured in bulk thus cutting production costs.  The 
fabrication technology is largely borrowed from the IC fabrication industry, but allows 
for the development of new products suited to this particular application.  These 
systems can be combined with signal processing and transmission electronics on a 
single–chip providing the advantage of reduction in size and bulk with the added 
possibility of powering through inductive coupling methods and telemetry [30]. 
 
The MEMS approach aims to provide in-situ monitoring of flow and IOP the changes as 
they occur when an eye is affected with glaucoma. MEMS technology will allow for the 
physical changes to be converted into electronically measurable quantities, storing and 
transmitting information to external electronic readout devices. This will enable the 
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patient or doctor to readily access the information when necessary and remove the need 
for a clinic-based measurement with the skill, time and costs involved. 
 
As MEMS technology can lend itself to the development of miniature implantable 
devices, the investigations will aim at deriving the requirements of a MEMS based 
method that will be capable of capturing any change in the level of Cf and IOP in the 
eye and providing a measurable indication of that change. The investigations will aim to 
arrive at the requirements of a system capable of delivering such a measurement by 
analysing the working of the eye and the principles behind glaucoma monitoring. The 
work to be undertaken in this thesis will focus on: 
 
1. Determining the factors that will be critical to making continuous Cf based IOP 
measurements from within the eye using a mathematical model. 
 
2. Developing the powering, size and sensitivity requirements of a system. 
 
3. Testing the output that will be obtained from such an implantable system. 
 
4. Determining the fabrication and production feasibility of a MEMS implant. 
 
This thesis is an extension of similar work undertaken by other researchers. 
 
1.4 Overview of chapters  
 
In Chapter 2, the literature review provides an introduction of the importance of Cf 
based glaucoma monitoring techniques. The principle and theory behind Cf 
measurements are described and the different methods of undertaking Cf measurements 
are explained. This chapter covers details of currently existing clinic-based IOP 
measurements, followed by an explanation of the alternate IOP measurement methods 
proposed in the literature. The use and applications of existing miniature glaucoma 
surgical implants is introduced and finally a discussion about recently developed 
MEMS IOP sensors in the literature is presented. The need to achieve a continuous Cf 
based IOP monitoring method is brought out at the end of the literature review. 
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In Chapter 3, the need for the use of a mathematical model of the eye is deduced by 
analysing the working of the eye and the role of the flow pressure equilibrium in Cf 
based IOP monitoring. A mathematical model of the eye that can capture the time based 
IOP activity of the eye that incorporates changes in eye volume and rigidity is 
introduced. The use of the model is validated by comparing the IOP output to that 
obtained from a tonometer. The sensitivity of the model to changes in the eye due to 
glaucoma is tested. 
 
In Chapter 4, the mathematical model is used to investigate the requirements of 
conducting an internal Cf based IOP measurement. The energy and size requirements of 
a miniature device and the sensitivity and resolution of a pressure sensor that is capable 
of monitoring glaucoma internally are determined.  
 
In Chapter 5, a MEMS based piezoresistive sensor is characterised for measurement of 
IOP as a surface load. The deflection of the sensor and the pattern of stress variation 
when subjected to IOP loads are analysed. These analyses assist in determining the 
optimal location of piezoresistors on the surface of the sensor and are used to calculate 
the electrical output that would be obtained from the sensor. The structural dimensions 
of the sensor, its resolution and the output voltages that are obtained from it are 
calculated and summarised at the end of this chapter.  
 
Chapter 6 provides an overview of the integrated MEMS system and options for 
enabling signal conditioning, powering and data transmission. The response that is 
obtained if a miniature device were implanted in the eye is tested under worst case 
operating conditions. The sensitivity of the electrical output that is obtained when a 
MEMS pressure sensor is combined with the device to difference in Cf levels is then 
determined using the mathematical model. 
 
In the seventh chapter a brief description of the type of actuator that can be used for the 
development of a MEMS device is provided along with possible fabrication and 
packaging details for the device and pressure sensor. Issues with reference to 
biocompatibility and implanting the MEMS system are discussed. 
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1.5 Results Achieved 
 
The use of a mathematical model describing the working of a device inside the eye of 
time based IOP and volume changes for providing continuous Cf based IOP 
measurements were investigated. The requirements of a miniature device that could be 
used to make internal Cf based IOP measurements were derived from the investigations. 
The requirements of a MEMS pressure sensor to measure IOP was determined. The 
working of the device and sensor were tested using the mathematical model and the 
sensitivity of the measurement to differences in Cf values is presented. The powering, 
fabrication and packaging details of the MEMS system are discussed.  
 
 
1.6 Contributions 
 
 A paper entitled “A MEMS Glaucoma Monitoring Device” has been published in the 
International Society for Optical Engineering Journal (SPIE) and a poster presentation 
was given during the International Symposium for Micro and Nano materials at 
University of Technology in Sydney held 11-15 December. 
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2 Literature Review 
 
 
2.1 Introduction 
 
The previous chapter demonstrated that glaucoma is a threatening condition that 
results in irreversible vision loss in humans and animals. The literature review 
will highlight the importance of Cf based IOP monitoring and the steps involved 
in undertaking it. Current glaucoma monitoring techniques are introduced in this 
chapter along with information about recently developed alternate methods of 
measuring IOP and existing miniature glaucoma implants. Information about the 
use of MEMS technology for the development of sensors to monitor IOP is 
included in the review to make a comparison between existing technologies and 
determine the kind of advancements that will be required to make Cf based IOP 
monitoring continuous and implantable. 
 
 
2.2 The importance of Cf based IOP monitoring  
 
It was shown in the previous chapter that the blockage of fluid flow in eyes leads 
to rise in IOP that can be detected by monitoring a decrease in the level of outflow 
facility or Cf, a parameter that is reflective of an increase in flow blockage. 
Currently the disease is controlled by managing the IOP levels of a patient by 
administering the appropriate medication or by  laser or incisional surgery. 
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 2.2.1 Cf measurement 
 
The level of outflow facility in the eye is defined as the rate of outflow of aqueous 
per mmHg of raised IOP per minute with the units, μl/min/mmHg [31]. It is taken 
to be the reciprocal of resistance to outflow, represented by the symbol R 
(R=1/Cf). A decrease in the level of outflow facility accompanies an increase in 
the level of resistance indicating an increase in the obstruction to fluid outflow 
from the eye.  
 
The values closer to 0.3 μl/min/mmHg indicate normal outflow facility and the 
values closer to 0.15 μl/min/mmHg are regarded as being indicative of severe 
fluid blockage [32].  
 
Detecting an increase in Cf levels requires continuous measurement of outflow 
facility along with flow and IOP levels in the anterior chamber of the eye [32]. 
These measurements then offer the possibility of administering timely corrective 
action by picking up the development of near critical conditions in the eye which 
inturn facilitate the treatment and management of glaucoma. Thus, eliminating the 
risk of blindness [33].  
 
Clinical Cf based glaucoma monitoring involves raising IOP temporarily and 
measuring its time based fall. A change in eye volume is used to cause a 
temporary change in IOP and Cf measurements are made from the time based 
pressure volume relationship of the eye represented in Equation 2.1 given in [13]. 
 
Cf =   ΔV/ T (P av – [P- Pv] )                                                                       (2.1) 
 
Where 
 
         Cf    =   the coefficient of outflow facility (μl/min/mmHg) 
         ΔV   =   change in eye volume (µl) 
          Pav  =    average of initial and final IOP during measurement (mmHg) 
          P    =   IOP in the eye (mmHg)  
          Pv   =   exit pressure (mmHg) 
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             T       =   measurement time (minutes) 
 
Research has shown that the presence of either raised IOP or low Cf alone could 
falsely indicate glaucoma [34], but a measurement that allows the clinical 
interpretation of both the parameters simultaneously will be able to provide a true 
indication of the extent of glaucoma in the eye. Although the monitoring of Cf 
values helps to determine any change or increase in glaucoma, the process in itself 
is not direct and depends on a host of other variables in the eye [35]. The transient 
nature of those variables is heightened by the onset of glaucoma and adds to the 
complexity of Cf based glaucoma monitoring [35]. 
 
2.2.2 Tonography  
 
The name given to the clinical method of measuring Cf is tonography. It is defined 
as the continuous measurement of IOP to determine the facility of outflow to 
determine the presence of glaucoma [24]. The changes in IOP produced by the 
constant application of a known external weight over the globe of the eye are 
recorded over time in tonography. The weight causes an instant elevation of IOP 
along with simultaneous changes to fluid inflow and outflow rates. The rate of fall 
of IOP is then measured after the removal of the weight. The phenomenon is 
illustrated in Figure 2.1 [36]. 
 
                                     
 
 
 
 
 
     
ForceF   in
     IOP 
       &        
 
Volume 
 
Figure 2.1 Principle of Tonography 
 
    
A change in the net volume of the eye is brought about during the measurement 
when fluid inflow is increased by the weight of the instrument. Additional fluid 
reduces the eye volume and leads to an instant rise in IOP. The eye then naturally 
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regulates flow and reduces the raised IOP. Outflow facility is calculated in 
tonography by the loss in volume expressed in terms of a difference in time 
between the fall of raised IOP to the original level (refer Equation 2.1). When 
affected with glaucoma the eye loses much of its flow regulating and IOP 
stabilising mechanism [32].   
Figure 2.2 depicts Friedenwald’s nomograms that were traditionally used to 
calculate Cf values [37]. The logarithmic values of initial and raised IOP values 
were included along with variations in the rigidity of the eye and the Cf values 
were manually interpreted by numerical fitting of the data from a standard 
nomogram. 
 
 
Figure 2.2   Friedenwald ‘s nomogram used to calculate Cf values[13] 
 
Towards the eighties computerised methods of interpreting and calculating Cf 
were introduced but they have not been standardised yet [38]. A detailed 
discussion relating to the exact method of calculating Cf has not been included in 
this literature review as it warrants intricate clinical knowledge and discernment 
which is outside the scope of this thesis.  
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A tonograph is the name given to the electronic reading obtained while recording 
the rate of fall of pressure in an eye during tonography. An illustration of a sample 
tonograph is provided in Figure 2.3. A tonograph resembles a pressure decay 
curve where a rate of fall of lesser than 25% a minute indicated a pronounced 
blockage and rate of fall of 5% per min indicated minimal blockage [23].  
 
               
                                               Time (minutes) 
     
 
     IOP 
     (mm 
        Hg)
                              Figure 2.3   Illustration of a sample tonograph [35] 
 
2.2.3 Different methods of measurement 
 
The Different kinds of instruments used in tonography are listed below in Table 
2.5. All the methods rely on the principle of initiating a rise in IOP by changing 
the effective volume of the eye externally and the difference lies in achieving the 
change. 
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 TYPE SENSOR RANGE METHOD ACTION FUNCTION REFERENCE 
Indentation 
Tonography 
Pressure 
Sensor 
0-50 mm 
Hg 
Schiotz 
Tonometer. 
Constant 
depth 
indented on 
cornea over 
4 mins 
Measure  
IOP and Cf 
from 
tonogram 
39 
Manometry - 
0-50 mm 
Hg 
Needle to 
inject fluid 
into eye 
Fluid 
reservoir 
connected to 
u-tube 
manometer 
to read 
pressure for 
4 mins 
Measure IOP 
and Cf from 
tonogram 
23 
Suction cup 
Tonography 
- 
 
0-50 mm 
Hg 
Vacuum 
cup placed  
over eye 
Suction cup 
connected to 
manometer - 
read pressure 
for 4 ins. 
 
Measure IOP 
and Cf from 
tonogram 
39 
 
Table 2.1 Different methods used in tonography . 
 
 
The main methods used to change the volume of the eye during tonography 
measurements are described in the following paragraphs.  
 
Manometry 
Manometry involves direct cannulation of the anterior chamber with a needle to 
increase IOP in the eye. The effective internal volume of the eye is reduced in 
manometry by adding water through a needle that is connected via a tube to a 
(saline) fluid filled reservoir [23]. The change in volume causes an instant rise in 
IOP required for the measurement.  The use of the manometer has been restricted 
to animal research in literature as the process requires anaesthetisation and is 
painful to administer. 
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 Indentation Tonography 
A Schiotz tonometer is used to indent the eye and alter the flow and IOP 
equilibrium due to the effective reduction of the net volume of the eye. A 
tonograph produces a recording of the rate of fall of IOP dropping with time and 
the extent of the blockage was interpreted from the rate of fall. A nomogram was 
to calculate the Cf values. Weights ranging from 1 gram to 5 grams are used to 
indent the eye for measuring IOP using a Schiotz tonometer [23]. 
The use of the Schiotz tonometer was the most popular method of measuring Cf in 
human eyes [36]. However it is not in use these days and is restricted to research 
purposes. Figures 2.4 and 2.5 below illustrate the method by which the 
measurement is administered. 
 
                            
Figure 2.4                                                                                       Figure 2.5 
Measurement of IOP using a Schiotz tonometer [13] 
            
 
Suction Cup tonography             
 
In suction cup tonography, a circular cup was placed over the eye and sealed into 
place with vacuum. The cup occluded the outlets and prevented the outflow of 
fluid. The effect of the weight of the cup was similar to the weight of a Schiotz 
tonometer and produced the same effect of reduction in eye volume. The rate of 
fall of IOP was noted as a measure of the eye’s response to the alteration in flow-
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pressure equilibrium and the level of (Cf) was calculated from the IOP response 
[23]. 
 
The tonography type measurement methods of have been described to be painful 
in the literature as they require the use of anaesthetics for the measurements [40]. 
Consecutive readings did not yield similar results [41]. However it can be 
summarised that the measurement of Cf levels had the potential to indicate the 
presence of glaucoma. 
 
 
2.3 Current glaucoma monitoring methods 
 
Currently Glaucoma is monitored by instantaneously measuring IOP using 
tonometers in a laboratory set-up.  
 
2.3.1 Tonometry 
 
The principle of tonometry is based on the Imbert-Fick law [42], which assumes 
the eye to be a fluid filled spherical system. The Imbert-Fick law states that if a 
plane surface is applied with a force F on to a thin spherical membrane within 
which a pressure P exists then for an equilibrium condition the expression is given 
by Equation 2.2. 
 
                                P =  
A
F                                               (2.2) 
where,  
                          P =    IOP 
                          A =   area of the applied force (3.06mm diameter or 1.732 mm2 ) 
                          F =   weight applied on the eye (1-10 grams)     
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 IOP   = F/A 
 
A = Const = 3.06 mm 
 
   F = 1g - 10g 
   F
IOP 
A
                            
 
Figure 2.6 Illustration of the Imbert-Fick law in Tonometry    
 
 
As pressure is equal to the force applied per unit area, placing the instrument over 
the eye gives an immediate indication of the IOP. Most of the IOP measurement 
methods are based on the applanation technique which is based on the Imbert-Fick 
law which is illustrated in Figure 2.6.                
 
2.3.2 Different Kinds of Tonometers 
 
Different kinds of tonometers are listed in Table   2.2 below. 
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Table 2.2 Different types of tonometers 
Type Sensor Range Method Action Function 
Applanation      
Tonometer Pressure Sensor 
0-40mm Hg 
Goldmann  
tonometer 
 
Variable force 
applied on 
constant area of 
cornea 
 
Measure IOP 
instantly 
[43] 
Indentation 
Tonometer 
 
Pressure Sensor 
0-50 mm Hg 
Schiotz 
Tonometer. 
Depth indented 
into cornea using 
constant force 
 
Measure IOP 
instantly 
[44] 
Non contact 
Tonometer 
Photoelectric 
sensor 
0-50 mm Hg 
Air-Puff  
applanation 
Area on cornea  
flattened by 
pressurised air 
jet 
 
Measure IOP 
instantly 
[44] 
MacKay Marg 
Tonometer 
 
Time record of 
force 
0-50 mm Hg 
Spring plunger 
footplate 
arrangement 
 
Estimate IOP 
from time record 
of force 
[44] 
Automated 
Handheld 
Tonometers 
Pressure sensor 0-50 mm Hg 
Tonopen 
tonometers 
Miniature 
tonometers based 
on Goldmann 
applanation 
Measure IOP 
instantly 
[44] 
Applanation Tonometry  
 
Applanation tonometry has been adopted as the universal standard measurement 
principle for external IOP measurement [44]. The measurement method is based 
on the Goldmann applanation principle. In this method the instrument is mounted 
on a clinical slit lamp bio-microscope and a probe like structure is impressed upon 
the cornea to flatten a circular area of diameter 3.06 mm using a knob. A force is 
imparted on the eye through the probe, which is varied between 1 and 10 grams to 
measure IOP between 5 to 50 mmHg within the eye. Patients require the 
assistance of either a skilled operator or an Ophthalmologist, who has access to 
these facilities as illustrated in the Figures 2.7 and 2.8.    
 
 
 
                                      
Figure 2.7 Measurement of IOP [13]                               Figure 2.8 Goldmann tonometer [13] 
 
 
Indentation Tonometry 
 
In Indentation tonometry a Schiotz tonometer is used to apply a known weight on 
the eye and the extent of indentation on the cornea is measured. This method is 
also based on the Imbert-Fick law. But unlike in the applanation principle in this 
case the depth to which the instrument sinks in the eye is measured. It has been 
recorded that indentation tonometry causes IOP to be raised due to the weight of 
the instrument and produces a falsified reading of IOP [44]. 
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A variation of the indentation type of tonometry is non-contact or air-puff 
tonometry where a stream of pressurized air is impressed on the cornea from the 
instrument. The amount of flattening caused on the cornea is then sensed using a 
photoelectric sensor. IOP is then calculated from the known force of the air stream 
and the photo electrically sensed diameter of applanation at the exact instant [44]. 
 
 
 Mackay-Marg and Tonopen Tonometers 
 
The Mackay-Marg tonometer is another variation of indentation tonometers where 
IOP is obtained as an estimate of the time record of the force used to counteract 
corneal bending pressure and the IOP within. The calibration and interpretation of 
this particular pressure measurement has been described to be complicated [45]. 
The tonopen or pneuma tonometer is a compact and mobile tonometer based on 
the Goldmann applanation principle that was designed for use without the need 
for a laboratory set up as in the case of the other tonometers [44]. Figure 2.9 
below shows an illustration of the tonopen tonometer.  
 
 
 
Figure 2.9 Tonopen Tonometer [105] 
 
 
Despite its availability it has not been able to replace the Goldmann applanation 
tonometer which remains the standard tonometer for clinical purposes today. 
Tonometers play an indispensable part in the treatment of glaucoma. Figure 2.10 
illustrates the different kinds of tonometers. Operating these instruments requires 
the time and efforts of skilled operators. IOP measurements are performed once 
every three months, over a 12 hour period to assess the efficiency of treatment 
[36]. The readings obtained from a tonometer are collected over the period of a 
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day to study the trend in fluctuation of IOP. Changes to the treatment routine are 
made with inference from the results to maintain a target IOP level in a patient 
 
 
 
 
Figure 2.10 Different types of tonometers   [13] 
.   
 
Though tonometers can be used for taking instantaneous IOP measurements and 
are used by physicians to assess the efficiency of treatment being provided, this 
measurement does not help to indicate any change or rise in the condition of the 
disease occurring at times outside of the measurements.  
 
 
2.4 Alternate IOP measurement methods 
 
The following section of the review will focus on recent attempts undertaken to 
replace tonometry by continuous IOP measurements.  
 
2.4.1 Miniature methods to monitor IOP 
 
C.C. [46] Collins developed the first miniature pressure sensor to record IOP 
information continuously in 1967 and since then an extensive amount of research 
has been devoted to the development of candidate technologies that could be used 
to replace tonometer measurements. Various transduction methods that could be 
utilised to sense and monitor IOP have been reported in literature. The different 
methods are described in Table 2.3. 
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DATA 
TRANSMISSION 
RANGE 
TYPE OF 
IMPLANT &SIZE 
FUNCTION REFERENCE METHOD 
Magnetic 
Permeability 
Not specified 
50-150 
kPa 
 
 
Implantable in the 
Lens. 6.76mm2
Measurement 
of IOP 
47 
Doppler 
effect 
Not specified 
50-150 
kPa 
 
 
Detect IOP based 
shift in frequency of 
eye 
Measurement 
of IOP 
48 
Strain gauge 
RF transmission with 
antenna on contact 
lens 
Not 
specified 
Relate change in 
radius of eye to IOP 
Measurement 
of IOP 
49 
Capacitive 
pressure 
sensor 
RF transmission with 
on chip antenna 
14-220 
kPa 
Implantable in Lens-
with a silicone 
coating 
6.25mm2. 
Measurement 
of IOP 
50 
Micro 
mechanical 
Tonometer 
Not specified 
50-150 
kPa 
6mm by 6mm 
Measurement 
of IOP 
51 
                                                                   
Table 2.3 Transduction methods to measure IOP. 
 
 
Researchers have pursued the feasibility of utilising physical phenomenon such as 
magnetic permeability and ultrasound Doppler effect as alternate approaches to 
IOP measurement. It has been suggested that a pressure sensor be coupled to an 
element whose change in magnetic permeability could be related to a change in 
IOP [48]. The detection of a shift in resonance of the eye shell when subjected to 
an audio signal by the ultrasonic Doppler effect has been reported to have the 
potential to monitor IOP [49]. The development of micromechanical tonometers 
has been reported [51]. However these methods require extensive experimental 
evidence and validation to be clinically accepted as standard forms of IOP 
measurement.  
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 2.4.2 Discussion 
 
 From this section it can be inferred that the miniaturisation of tonometry has been 
attempted and several alternative methods of IOP measurement have been 
reported in the literature. However, it can be seen none of them have succeeded in 
replacing external tonometry measurements and have not included any aspect of 
Cf based glaucoma monitoring. 
 
2.5 Miniature glaucoma implants  
 
This section provides information about a class of clinically significant glaucoma 
implants that are being used successfully.  The technology and methods employed 
for the development and use of these implants will be discussed here. 
 
2.5.1 Surgical implants 
 
Miniature implants developed for the treatment and surgery of glaucoma have 
been successful and are currently in use. The implants are mainly micro-surgical 
devices that are used mainly for pressure regulation purposes and are implanted in 
regions close to the anterior chamber of eye, where most of the drainage occurs 
(Refer Section 1.2.2).  
 
The implants reduce IOP in the eye by promoting fluid flow when there is a 
severe blockage that cannot be treated by surgery or medication. They are 
designed to allow fluid to flow either through in-built tubes or across their flat 
surface to bypass blockages and successfully drain out through the drainage 
channels [52]. They are also used to keep a surgically created outlet in the 
person’s eye for fluid drainage from closing [53]. These micromechanical 
implants are compact enough to be surgically positioned under the white (sclera) 
of the eye or in close proximity to the anterior chamber.  
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 The microsurgical implants can be divided into two broad categories  
 
1. Drainage devices & 
2. Glaucoma valve implants 
 
The drainage devices are designed to dissolve a few months after implanting 
under the white of the eye. The devices dissolve leaving behind the space 
occupied by them, which allows fluid to drain out of the eye keeping IOP low. 
They are often up to 19 mm in length and 1 mm wide.  
 
The valve implants are larger drainage devices [27] which have been used in the 
treatment of glaucoma patients since 1969.The valves help to increase outflow of 
fluid from eyes to keep pressure low. The valve consists of a long tube which is 
inserted into the anterior chamber in front of the iris allowing the fluid to pass 
across it to the back of the eye, where the rest of the implant is located. 
Illustrations of valve implants and drainage devices are presented in Figures 2.11, 
2.12 and 2.13. 
 
                                         
Figure 2.11 Location of valve implants [54] 
                                1. Tube in anterior chamber 
                                2. Flat plate of implant under sclera, behind anterior chamber 
 
 
Micro pressure valves have been developed to help with filtering of excess fluid 
in the eye when surgery or treatment fails to reduce and regulate IOP levels. The 
miniature valves developed for this purpose are not more than 5×5×2 mm3 in 
volume and are known as Molteno and Ahmed valve implants. They are 
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manufactured to assist with artificial IOP regulation and assist with glaucoma 
treatment after surgery [54].  
 
 
                         
         
                   Figure 2.12 Valve implants [54]                         Figure 2.13 Drainage devices [54] 
 
 
There have been reports of electrochemically powered self-actuating, automatic 
pressure regulators capable of maintaining IOP under the required target level 
[55]. The purpose of these implants was to maintain IOP at a certain level by 
controlling fluid-flow in the eye by using a micro-valve integrated with a pressure 
regulating device.  Implants of this type are still under development at the MESA, 
Research institute, in the University of Netherlands. 
 
The problems associated with such micromechanical implants are that they may 
not function effectively over time due to the possible clogging of the tube with 
tissue. Scarring may occur around the implant and prevent re-absorption of fluid 
into the eye from the drainage areas. As implanted valves are foreign bodies, 
inflammation and bleb formation could occur in the eye after surgical 
implantation. Surgically created holes for drainage of fluid inside and in regions 
around the eye heal with time which then renders the flow and pressure regulation 
valves ineffective.  
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 2.5.2   Discussion 
 
Literature shows evidence of miniature devices designed to regulate and control 
IOP inside the eye. Although they provide invaluable assistance in glaucoma 
treatment there are considerable problems associated with the use of surgically 
implantable micro-mechanical devices and surgical glaucoma implants.  
 
Despite their advantages these implants will not be able to provide an early 
indication to a patient of the onset of critical conditions inside the eye as they are 
not linked to Cf based glaucoma monitoring. Though the miniature surgical 
drainage and pressure regulation devices are not equipped to monitor any changes 
in the Cf levels of the eye the technology used for the development of these 
implants and the surgical procedures associated with their use suggest that it will 
be possible to undertake the development of a miniature implantable glaucoma 
monitoring device based on the support of similar relevant medical and 
technological knowledge. 
 
 
2.6 MEMS based miniature IOP sensors  
 
It was introduced in Section 1.3 that MEMS technology has the potential to 
combine sensing and actuating mechanisms alongside with signal processing and 
transmission electronics on a single implantable chip. The technology presents the 
possibility of integrating powering and transmission components onto a single 
chip which will make the availability of MEMS devices capable of continuously 
monitoring and transmitting data possible. Ocular implants, blood-glucose 
monitors, drug-delivery systems and implantable pressure sensors are some of the 
interesting outcomes from the advancements in MEMS technology [30]. 
 
Recently this technology has been favoured for the production and development 
of miniature IOP sensors [28]. The objective behind the development of 
implantable MEMS pressure sensors was to replace one-off laboratory based IOP 
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measurements for glaucoma patients and make continuous IOP monitoring readily 
available.  
 
2.6.1 MEMS IOP sensors 
 
As MEMS sensors allow for the sensing and transmission electronics to be made 
available on a single microchip the IOP readings recorded from an implanted 
sensor are transmitted through the integrated signal conditioning units to external 
read out units or hand held devices [56].   
 
The methods adopted by the MEMS sensors to measure IOP are similar to the 
pressure sensing methods used for industrial and automotive applications. 
Therefore the measurements are reliable and trusted methods are used to fabricate 
and package the devices. Table 2.4 lists the different types of implantable MEMS 
sensors proposed in the literature that have the capacity to monitor IOP.  
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Table 2.4   Different MEMS IOP   Sensors Proposed in literature. 
 
SENSOR-
MECHANISM 
DATA 
TRANSMISSION 
REFERENCE 
PRESSURE 
RANGE 
SIZE OF SENSOR 
CHIP 
FUNCTION REFERENCE 
Diaphragm 
movement 
Capacitive element 
RF transmission with on 
chip antenna 
Absolute 
(measured 
against vacuum 
as reference 
pressure). 
80-130 kPa 
 
 
Implantable in eye 
lens. 
2.6mm×2.6mm & 
10.5mm antenna 
Continuous 
measurement of 
IOP 
[56] 
Diaphragm 
movement 
Capacitive and 
Piezo resistive 
elements. 
Not specified Absolute N/ A Not specified 
Continuous 
measurement of 
IOP 
[57] 
Diaphragm 
movement- 
Capacitive Sensing 
On Chip-Frequency 
transmission 
Absolute 
reference 
0- 26kPa 
Implantable 
0.8mm×3.8mm and 
telemetry chip 
Continuous 
measurement of 
IOP 
[58] 
Strain Gauge based 
sensing 
RF transmission with on 
chip antenna 
None N/A 
Strain gauge 
sensors  built onto a 
contact lens 
Continuous 
measurement of 
IOP 
[59] 
  
It can be seen from the table that absolute capacitive pressure sensing technology 
has remained the most popular method for developing MEMS IOP sensors. The 
MEMS capacitive pressure sensing is based on the parallel plate capacitor theory 
[60], where the sensor consists of a movable sensing element and a fixed 
reference element (which could both be several arrays of miniature capacitive 
elements). When an external pressure load is applied on the movable plate 
(sensing element) of a parallel plate capacitor, the plate deflects in proportion to 
the applied pressure. The deflection changes the distance between (vacuum gap) 
the fixed and movable plates of the capacitor, which results in a pressure 
dependent change of capacitance that is detected as a voltage change. The relation 
between capacitance, charge, voltage and movable plate dimensions are given in 
Equations 2.3 and 2.4 below [60]. 
 
               
V
QC =                                                                (2.3) 
Where 
x
εεA
C 0
××=                                                        (2.4) 
 
    C=   Capacitance  
    A=   Area of the electrodes (depends on height (h), length (l) and thickness (t)) 
    ε =  Relative permittivity of the medium between the electrodes usually taken  
             as 1 for air 
    ε0 = 8.854 × 10-12 F/m (permittivity of vacuum) 
    x = distance between the two plates 
 
The dimensions of the movable plate (h, l, t) are adjusted to suit the sensitivity of 
the sensor. The parallel plate capacitor is connected to either to a LC circuit [61] 
or to a integrator and amplifier [62] for detecting the change in voltage. 
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The use of MEMS strain gauges embedded onto contact lenses that can relate 
fractional changes in IOP to a change in the radius of the eye have been reported 
recently [59]. The sensor arrangement could be connected to external telemetry 
equipment that will allow for transmission of the pressure recordings to an 
external source. The differential changes in radius of the external eye (cornea) due 
to change in IOP causes a corresponding change in the output of strain gauge 
embedded into a contact lens. The method promises to be a good alternative to the 
capacitive sensing method that requires surgery for implantation. The output of 
the strain gauge is monitored to observe changes in IOP. Miniature antennas have 
to be integrated along with the sensors to allow for the transmission of IOP data to 
an external recording device. 
 
2.6.2 Sensor based monitoring system  
 
The main components of a MEMS based pressure sensor system can be divided 
into the sensing element, signal conditioning unit, power supply and transmission 
system. All these components integrated into a single device constitutes an 
implantable MEMS sensor system. 
 
Several groups have worked successfully to develop implants that can monitor 
pressure continuously using MEMS capacitive pressure sensors and have 
presented results with animal testing [56]. The reported implants are integrated 
within artificial eye lens implants or located at the back of the eye. Miniature 
signal conditioning units also accompany the microelectromechanical sensors. 
ASIC chips using CMOS electronics are used for processing and storing the IOP 
information. The sensor systems are accompanied by either temperature sensing 
and control or feedback systems to administer corrective action within the 
implanted system [58].  
 
The pressure sensor is coupled with an on chip or external antenna for 
transmission of data. Inductive coupling between an external primary coil and a 
secondary coil house in the implant provides energy to the sensor system. Radio 
frequency (RF) transmission based on inductive coupling has been reported to be 
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used for telemetry. IOP monitoring can be performed within a distance of up to 3 
meters by the use of such inductive coupling systems [56]. 
 
The presence of telemetry components increases the size of the sensor implant. 
The transmission antenna [31] is often the largest component in this type of single 
chip miniature implants. All three systems integrated together on a single chip 
constitute a MEMS implantable sensor system. 
 
The implantable sensors can be used to record IOP data continuously and allow 
for frequent IOP measurements. 
                              
 
2.6.3 Discussion  
 
It can be noted that implantable MEMS based sensor systems allow for 
continuous IOP measurements. Though these sensors have the potential to replace 
tonometry and make IOP measurement continuous they do not possess the 
capability of monitoring the Cf levels of a patient. Whether or not the MEMS 
technology can be utilised for Cf monitoring remains to be investigated.  
 
 
2.7 Conclusions  
 
The literature review has highlighted the following key points. Cf based IOP 
monitoring has the potential to detect the onset of glaucoma, but the actual 
measurement procedure is complex and hence the measurement is now restricted 
to research purposes. Existing monitoring methods and recent developments fall 
short of addressing the clinical monitoring aspect of glaucoma and there is no 
method to detect the onset of critical conditions in a patient.  
 
MEMS technology has the potential to provide an integrated monitoring system 
for glaucoma capable of fore warning threatening conditions to a patient and 
micro machined MEMS implants have been developed to surgically assist and 
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treat glaucoma. However, no attention has been devoted to the development of a 
Cf based IOP monitoring system. 
 
The miniature pressure sensor outputs that have been quoted in the literature have 
not been characterised to monitor Cf based IOP measurements. The requirements 
of a system that can provide in-situ monitoring of glaucoma have to be 
established. Making the measurement internal and continuous would allow for 
real time monitoring of flow and IOP levels and pick up the changes in parameters 
as they occur and providing on-demand glaucoma monitoring to the patient.  
 
The method of conducting the measurement, its size and energy requirements will 
have to be determined. The characterisation of an IOP sensor that will capable of 
monitoring Cf and IOP will have to be undertaken, the range and type of output 
voltages that will be obtained from the measurement will have to be determined. 
Hence the requirements of a prototype MEMS device are investigated and its 
requirements are determined in this thesis  
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3 Method of Analysis 
 
 
3.1 Introduction 
 
In this chapter a mathematical model of the eye will be used to analyse how normal eye 
function is affected by glaucoma. The model will help to examine the principle behind 
IOP measurement and serve as the basis for undertaking further investigations relating 
to internal IOP measurement.  
 
 
3.2 Functioning of the eye  
 
Researchers have observed that the working of the eye can be compared to a fluid-
pressure system within a deformable volume where the amount of fluid entering is in 
equilibrium with the amount leaving. Adler’s text [13] provides a graphical description 
of the fluid-pressure system which forms the basis for undertaking glaucoma monitoring 
measurements. An illustration of the system is provided in figure 3.1 below. 
In Figure 3.1 the presence of a blockage at the outlets is indicated by R0 values. The R0 
values represent the resistance to fluid flow at the eye outlets, their reciprocal is given 
by R0 = 1/Cf, where Cf represents the outflow facility level in the eye. As depicted in 
Figure 3.1, as a blockage intensifies the values of R0 increase and the value of Cf 
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decreases correspondingly. Thus eyes with a low value of outflow facility are taken to 
represent a severe fluid blockage that triggers a host of pathological conditions that are 
collectively described as glaucoma [23]. 
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           Rate  
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Figure 3.1Relation between flow rate, IOP and resistance to outflow in the eye. [13] 
 
The presence of a blockage to fluid flow triggers the eye’s natural regulatory 
mechanism, which increases fluid production rates (depicted by the lines rising upwards 
in the Figure above). The increase in fluid production is not matched by the outflow 
rates (shown by dashed lines falling down) due to the presence of a blockage. This leads 
to a change in the flow equilibrium of the system.  
The eye’s working balance is maintained by a balance of a steady state IOP at balanced 
flow equilibrium. As the flow equilibrium is altered on account of the blockage, IOP 
rises and stabilises at a higher level than before. The altered flow rates stabilise with 
time at the higher IOP as illustrated by the Figure 3.1 points where the inflow and 
outflow lines intersect). The cycle continues as long as the blockage intensifies and the 
system continues to stabilise after every change in equilibrium at higher values of IOP. 
Thus the working of the eye can be compared to that of a closed loop system with 
positive feedback as illustrated in Figure 3.2 below. 
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Figure 3.2   Eye depicted as a closed loop system with positive feed-back. 
 
The Figure 3.2 illustrates the phenomenon described by Figure 3.1 which can be 
explained as the higher the flow blockage the greater is the resistance at the outlets. The 
lowering of Cf values and rising of IOP accompany this. Glaucoma research [23] has 
indicated that tonography type (refer section 2.3) glaucoma measurements that involve 
measuring both outflow facility (Cf ) and IOP levels in a patient  can provide a warning 
of an imminent rise in IOP [24]. The major variables linked with this measurement are  
 
1. IOP  
2. Volume of the eye (V) 
3. Rigidity of the eye (K) 
4. Out flow facility of the eye (Cf ) 
 
where IOP is intraocular pressure in the eye, the volume of the eye (V) describes the 
extent of fluid that can be contained within the eye. The rigidity of the eye (K) refers to 
the elastic nature of sclera (transparent outer covering) of the eye and outflow facility 
(Cf) is described as the ease with which fluid can leave from the outlet channels of the 
eye. The influence diagram in Figure 3.3 below illustrates the link between the variables 
and IOP. 
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Figure 3.3 Influence diagram indicating the major variables involved in cf based glaucoma 
monitoring [35] 
 
Evidence in the literature suggests all the variables depicted in the influence diagram 
impact on Cf based IOP measurement. Some of the variables vary within a given range 
while others remain constant during the measurement [44], [63]. The range of the 
variables to be monitored are 
 
 
1. IOP             -             10-mmHg -35 mmHg  
2.  Flow Rate   -              2 µl/min -3 µl/min 
3.  Volume     -               250 µl  
4.   Cf              -              1.5 µl/min/mmHg -3.0 µl/min/mmHg 
 
 
The values require that the accuracy and precision of the measurements be within the 
micro-range. During external Cf based IOP measurements eye volume is reduced using 
a force [24], IOP rises to a higher value instantly upon changing eye volume and then 
decays with time. The change in eye volume is held till the eye responds by reducing 
IOP back to original level. Although a Cf based IOP measurement is dependent on the 
pressure, volume and flow relationship of the eye and involves the impact of a host of 
other related variables, it has been known to possess the potential to indicate any 
impending rise in IOP. Therefore an equivalent model of the eye will be required to 
study the principle behind the working of the eye and Cf based IOP measurement for 
glaucoma monitoring.  
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 3.3 Time dependent model of the human eye 
 
Several mathematical models and formulations have been proposed for the study of the 
behaviour eye mechanics [64], [65], and fluid flow within the anterior chamber [66]. 
These models have been used as the basis for conducting surgery and taking 
measurements of the eye [67], [68]. However, a time dependent mathematical model of 
the eye developed and investigated by Collins and Van Der Werff [35] has been adopted 
in this thesis to study the principle behind the Cf based IOP measurement method. The 
model is based on previous models of the flow and pressure of the eye [69], [70], [71]. 
It has been modified to study the time-based response of the eye to glaucoma 
measurements. It has been noted that the results from Collins and Van der Werff’s 
model agree well with clinical measurement results on human eyes.  
Due to the lack of clinical test data, the model was tested in this thesis by inputting 
values used during typical clinical measurements into the mathematical model and 
studying the results obtained. 
A differential equation that describes the effect of volume changes on the fluid-pressure 
equilibrium of the eye forms the basis of the mathematical model. The differential 
equation governs the rate of change of IOP by taking into account the time-based effect 
of change in pressure of the eye due to changes in volume, flow rates, C f levels and 
rigidity. The derivation of the differential equation is presented below.  
 
3.3.1 Pressure dependence of flow and volume 
 
The derivation in [35] starts with Equation 3.1 which shows that a change in intraocular 
volume (dV/dt) includes a term which represents the change in the amount of aqueous 
fluid entering or leaving (dvaq/dt) along with a term to represent the  changes imposed 
on the eye volume (
dt
dv  ) 
 
dt
dv
dt
dVaq
dt
dV +=                                                                                      (3.1) 
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 The change in the amount of aqueous fluid entering and leaving (dvaq/dt) can be taken to 
be the rate of change of aqueous volume. This is represented in Equation 3.2 as the 
difference between aqueous production and outflow rates, both of which are pressure 
dependent.  
 
dt
dVaq
 =   ( ) ( )outfcp PIOPCIOPPC −−−                                                                                       (3.2) 
 
The terms Cp (Pc – IOP) and Cf (IOP - Pout) represent the pressure dependent fluid inflow 
and exit rates of the eye.  The term Cf represents the resistance at the outlets of the eye. 
Pc, and Pout stand for critical pressure at the outlet, outlet pressure respectively. The 
equation for rate of change of aqueous volume is rewritten substituting Equation 3.3 for 
Cf   and Equation 3.4 for P out, where the constants a1 and a2 are taken to be 0.05 and 
1.125, constants a3 = 0.48, a4 = 4.26 and the exit pressure, Pout = 9 mmHg respectively. 
These values are kept constant for all human eyes.  
 
                  ⎟⎟⎠
⎞
⎜⎜⎝
⎛
+⋅= 21
1
aIOPa
C f                                                                    (3.3) 
                    43 aIOPaPout +⋅=                                                                     (3.4) 
 
Thus a new equation for the rate of change of aqueous volume in terms of flow rate and 
pressure is given by Equation 3.5 below. 
 
dt
dVaq
  =  ( ) −− IOPPC cp   
21
43 )1(
aPa
aIOPa
+
−−
                                          (3.5) 
This equation represents the pressure dependence of the fluid flow rates which indicates 
that both the rate of change of eye volume and flow rates are linked closely to IOP. (The 
numerical values used for substitution into equation 3.5 are Cp = 0.046 μl/min/mmHg,  
a1= 0.0306 μl /min-1, a2 = 1.428 mmHg / μl/ min, a3 = 0.5 (dimensionless), a 4 = 4.26 
mmHg, and Pc = 50 mmHg as taken in the mathematical model in [35]. 
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 3.3.2 Pressure and volume dependence of rigidity  
 
A mathematical formulation, Equation 3.6, is used to describe the effect of including the 
viscoelasticity of the corneal shell of the eye along with the time dependence of rigidity 
and volume of the eye.  
ΔP = ΔV. Kt ( )                                (3.6) msts
mft
feq eKeKK
−− ++
 
Any change to intraocular volume will result in a change in IOP which will consist of 
an equilibrium pressure difference (ΔPeq), a fast relaxation curve (ΔPfast), and a slow 
relaxation curve (ΔPslow) as described in   Equation 3.7 
 
ΔP =                                                                (3.7) slowfasteq PPP Δ++Δ
 
Equation 3.6 can be rewritten to arrive at a formula that describes the volume based 
change in IOP in terms of rigidity.  
 
                   ΔP/ ΔV = Kt ( ) msts
mft
feq eKeKK
−− ++
                                                       Or 
dv
dp  = Kt ( )                                       ( 3 .8) msts
mft
feq eKeKK
−− ++
 
In Equation 3.8, Kt = ( Keq+Kf +Ks) which demonstrates that if a known volume is 
added into the eye it will alter the flow-pressure equilibrium. Alteration of the flow-
pressure equilibrium will result in a pressure rise that will be re-established after a 
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pressure decay. As described earlier, the resulting pressure decay will have an 
equilibrium pressure difference a fast relaxation component and a slow relaxation 
component (refer Equation 3.6).  The elements of the pressure decay are represented by 
the terms on the right hand side of Equation 3.8. The term Keq represents the rigidity of 
the eye and the terms Kf and Ks represent decaying exponentials that control the stress 
relaxation and the viscoelastic response of the eye. 
Thus the model includes the effect of stiffness of the eye along with the relaxation 
exponentials to capture and study the rate of fall of pressure required for Cf monitoring. 
The ocular and blood vessel rigidities in the equation have the values, Kf* = - 0.38, Ks* 
= - 0.47, mf   = - 1.803 min-1 and ms = - 0.072 min -1 respectively as taken in the 
mathematical model in [35]. Hence the Equation 3.8 can be used to calculate the 
pressure decay that would result in the eye after a change in volume.                          
If in the Equation for times t << 1, the terms in the brackets on the right hand side 
simplify to 1,  then the value of the equation reduces to Kt. Kt can also be substituted by 
(a × P+ b), the unifying formula for ocular rigidity, where a = 0.0123 μl -1and b = 0.0 
mmHg/ μl and Equation 3.8 can be rewritten in a new form as shown below. 
 
dv
dp  =   ( )                                   ( 3.9) ( ) mstsmftfeq eKeKKPa −− ++×
 
The equation indicates that the rigidity of the eye is linked with time based variation of 
eye volume and IOP. 
 
3.3.3 Time dependence of IOP  
 
Having illustrated the dependence of change in volume on IOP, flow rates, and rigidity 
of the eye, the rate of change of eye volume can be rewritten as shown in Equations 
3.10 and 3.11 below. 
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dt
dV  =   
dp
dV
 ×
dt
dp     or      
dt
dp  = 
⎟⎟
⎟⎟
⎠
⎞
⎜⎜
⎜⎜
⎝
⎛
dp
dv
dt
dv
                                         (3.10) 
dt
dp  = 
⎟⎟
⎟⎟
⎟
⎠
⎞
⎜⎜
⎜⎜
⎜
⎝
⎛
dv
dp
dt
dv
1
                                                                              (3.11) 
Equation 3.11 can then be rearranged by substituting the value of dv/dt by Equations 3.1 
and 3.2 and the value of dp/dv by equation 3.9. The new Equation 3.12 represents the 
governing equation for the rate of change of IOP.  
 
))(/(1
/)()(
mst
s
mft
feq
outfcp
eKeKKbaP
dtdVPPCIOPPC
dt
dp
−− +++
+−−−=            (3.12) 
 
Equation 3.12 is taken as the universal equation that describes the time-based variation 
of IOP as it includes the terms that represent changes in production and outflow of 
aqueous humor, rigidities of the human eye and changes in eye volume.  The effect of 
arterial pulsations that were included in the original model has been excluded here as 
this was outside the scope of this research. It was ensured that the removal of that 
parameter did not affect final output produced by the model.  
 
All pressure, volume, flow and rigidity values along with the constants and variables 
that have been used with the model lie within the original ranges used.  
 
3.4 Simulation and modelling results  
 
As the mathematical model (Equation 3.12) is based on the time dependent pressure–
volume relationship of the eye it was modelled using Matlab software. A number of 
simulations were conducted using the model to analyse the principle behind IOP 
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measurement by studying eye responses under the influence of glaucoma. For the 
simulations IOP was varied between 10 mmHg and 50 mmHg, the volume of anterior 
chamber was taken to be 250 μl, outflow facility (Cf) was varied between 0.15 
μl/min/mmHg and 0.3 μl/min/mmHg and the rigidity was varied by increasing Keq 
between 0.15 - 0.45 (dimensionless). 
 
3.4.1 Eye response to external measurements 
 
The mathematical model was used to study the eye response to external IOP 
measurements. When an instrument like a tonometer was used to measure IOP the 
output that would be obtained would be recorded in the form of a pressure against time 
graph as illustrated in Figure 3.4 below. In tonometry, applanating 1.02 ×10-5m2 on the 
surface of the eye using a 5.5 gram weight causes IOP to rise instantly and decay with 
time thereafter. 
 
 
         
                                                  Time (minutes)
         IOP 
        (mm 
         Hg) 
Figure 3.4 Illustration of a sample tonogram [35] 
 
The model was used to calculate the change in IOP that will be obtained if a 5.5 gram 
weight similar to the one that was used in the tonogram was used to applanate 1.02 ×10-
5m2 or take up 12.21 mm3 of eye volume. The outflow facility level was taken to be 0.33 
μl /min/mmHg, the value of rigidity was set at 0.15 and IOP was set at 15 mmHg in the 
model so that these values corresponded to the typical values for a normal eye. It was 
assumed that eye volume was changed in the first minute of the simulation. The results 
are presented in Figure 3.5 below. 
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Figure 3.5 Output from model 
 
It can be seen from Figure 3.5 that when values equal to those used in an external test 
are input into the mathematical model, it produces an output where IOP rises instantly 
after a change in eye volume. It has been quoted in the literature that a tonometer causes 
a 100% rise in IOP. However it can be observed from Figure 3.5 that the model shows 
that the initial rise in IOP is not as sharp as that in the tonogram and the rise in IOP less 
than 100%. As the effects of arterial pulsations have not been included in the model, the 
pulsations that are clearly visible in the sample tonogram (Figure 3.4) have not been 
reproduced in the model’s output. Thus it can be noted that the model is able to 
reproduce the pressure trend produced by a tonometer. The model output will be further 
tested to see whether it is sensitive to changes in Cf and K.  
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 3.4.2 Eye behaviour with glaucoma 
 
The information presented in Figures 3.6 and 3.7 represent the sensitivity of IOP to 
changes in outflow facility (Cf) and rigidity (K). 
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Figure 3.6 Effect of variation in Cf on IOP 
 
Figure 3.6 shows that the output obtained from the model changes with Cf values. It can 
be seen that as Cf decreases and IOP rises to higher levels. The rate of fall of IOP is also 
noted to change along with the Cf values. 
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Figure 3.7 Effect of  variation of rigidity values on IOP. 
 
From Figure 3.7 it can be noted that as the rigidity of the eye shell increases, there is an 
increase in the level to which IOP rises for a given volume based change over time. 
Thus it can be seen that the mathematical model is capable of producing a response that 
illustrates the sensitivity of IOP rise and fall to changes in Cf and K values. This aspect 
of the model indicates that it can be used to analyse the behaviour of an eye when it is 
affected with glaucoma. 
 
Hence it can be taken that the results from the model are comparable to those expected 
from external test measurements. The model can be used for further study and 
investigation of the requirements of MEMS based glaucoma monitoring system in this 
thesis. 
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 3.5 Conclusion  
 
The use of an experimental mathematical model of the eye is proposed and investigated 
for the analysis of an internal method of Cf based IOP monitoring by decreasing the 
volume of the eye. The capability of the mathematical model is illustrated by 
demonstrating its sensitivity to the key variables involved with the measurement. 
Comparing its output to that expected from external tests validates the use of the 
experimental mathematical model. The simulations have proven that the model will be 
useful for further study and investigation of glaucoma monitoring methods. 
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4 Investigating System  
   Requirements 
 
 
4.1 Introduction 
 
It was determined previously that in order to continuously monitor glaucoma by 
tracking Cf levels, the IOP had to be temporarily raised inside the eye and the time taken 
for it to fall back to original level recorded. The investigations into the requirements of a 
MEMS system that will be capable of raising and measuring IOP inside the eye are 
outlined in this chapter. The mathematical model of the eye presented in the previous 
chapter was used for the investigations. The investigations were used to collect 
information to help determine the requirements of a micro system that was able to create 
the changes in the eye to enable Cf  based IOP measurements. 
 
 
4.2 Investigations 
 
The first part of the investigations focused on deriving the requirements for raising IOP 
inside the eye and deriving the functional requirements of a suitable MEMS device from 
that method. The second part of the investigations determined the needs of a sensor that 
would be capable of capturing the required IOP measurements. 
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 4.2.1. Requirement to raise IOP inside the eye 
 
The objective of this section is to use the mathematical model of the eye to analyse how 
IOP can be raised inside the eye by 100% above the starting level. 
 
 
4.2.1.1 Effect of varying eye volume  
 
It is assumed in the mathematical model that the starting IOP in the eye is 15 mmHg. 
The value of outflow facility is taken as 0.30 mmHg/μl,/min and rigidity (K) taken at 
0.15 (no units). These values represent normal conditions in the eye. In the simulation 
internal eye volume is taken to be 250 mm3 based on the anterior chamber dimensions 
provided in [35] to be 250 μl, which represents the approximate volume of the anterior 
chamber. Eye volume is decreased by 45 mm3, 55 mm3, 65 mm3 and 75 mm3 using the 
model and the changes obtained in IOP for the different reductions in volume are 
presented in Figure 4.1 below.  
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Figure 4.1 Pressure rise obtained vs decrease in eye volume 
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Given that the mathematical model was developed on the basis of the pressure volume 
relationship of the eye, it can be seen from Figure 4.1 that reducing the effective internal 
eye volume causes a rise in IOP. It is observed that an approximate decrease of 65 mm3 
in eye volume would cause IOP to rise by 15 mmHg which would equal a 100% rise 
from the starting pressure level. As the anterior chamber volume was taken to be 250 μl 
or 250 mm3, decreasing its volume by 65mm3 would be equal to taking up 
approximately 26% of internal eye volume. 
 
4.2.1.2  Effect of varying duration of volume reduction.  
 
It has been determined that IOP can be raised by reducing eye volume. The following 
sections will investigate the requirements of a MEMS device that will be able to raise 
IOP in the eye by reducing eye volume. 
 
The following simulations were conducted to study the impact of duration of volume 
change on IOP rise. The values considered for the simulation were as follows: IOP = 15 
mmHg, outflow facility (Cf) = 0.30 mmHg/μl/min, Rigidity (K) = 0.15 (no units), 
decrease in eye volume = 65 mm3. The effect of providing volume reduction was 
studied over a period of several minutes and the results are presented in Figure 4.2. The 
symbol Tv in the figure represents the time at which volume reduction is commenced in 
the simulation. 
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Figure 4.2 Effect of IOP rise with time due to volume reduction. 
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 From Figure 4.2 it can be seen that providing a volume reduction causes IOP to rise 
from 15 to 30 mmHg (100% increase) under one minute. Under the effect of the volume 
change, IOP begins to fall rapidly after reaching a maximum and later stabilizes at 4 
mmHg above the starting level. 
 
Figure 4.2 illustrates that a pressure curve similar to the one produced by a tonometer  
(refer Figure 3.4) could be achieved inside the eye by creating a volume change within 
one minute and maintaining that change until the eye responds by reducing IOP. 
 
4.2.1.3 Effect of varying magnitude of volume reduction  
 
The following simulations were conducted to study the effect of magnitude and time-
based differences of volume change on IOP rise. The values considered for the 
simulation were as follows, IOP = 15 mmHg, outflow facility (Cf) = 0.30 
mmHg/μl/min, Rigidity (K) = 0.15, decrease in eye volume = 5-65 mm3. The effect of 
variation in the magnitude of volume reduction on IOP was noted for two minutes and 
results are presented in Figure 4.3.  
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Figure 4.3 Pressure rise vs time for different volume magnitudes 
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 It can be observed from the figure that the rise in IOP obtained by reducing 65 mm3 of 
eye volume would be 100%. The figure also shows that reducing volume by 5mm3 or 
less would cause little or no rise in IOP.  
 
It can be noted that the volume change is assumed to be provided instantly in the above 
simulations. The effect of delaying the time in which the volume reduction comes into 
full effect is studied by increasing the time taken to reduce eye volume by from one to 
four minutes approximately. The values considered for the simulation are as follows  
starting IOP = 15 mmHg, outflow facility (Cf) = 0.30 mmHg/μl/min, Rigidity (K) = 
0.15, decrease in eye volume = 65 mm3 .The results are presented in Figure 4.4. 
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Figure 4.4 Effect of IOP rise with delayed Tv
 
It can be seen that from the results plotted in Figure 4.4 that if the volume change is not 
provided instantly then IOP does not rise sharply. IOP does not climb to 100% even 
after the reduction in volume comes into full effect as it did previously when the volume 
reduction was provided instantly (refer Figure 4.3).                  
 
If the reduction in eye volume could be translated to an increase in the size of a 
potential device that could expand to take up 26% of eye volume, then such a device 
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could be used for raising IOP internally. It has been demonstrated earlier that a volume 
reduction of less than 5mm3 does not affect IOP. Therefore, the effect on IOP if a device 
of initial size less than 5mm3 were to be implanted in the anterior chamber whose size 
could be increased to approximately 65 mm3 within a minute, is simulated using the 
mathematical model.  The results obtained are presented in Figure 4.5 below.        
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Figure 4.5 Pressure rise Vs Time based on change in magnitude of volume reduction. 
 
 
The results show that the effect of reducing eye volume from 5mm3 to 65mm3 instantly 
would be similar to the IOP curve obtained from a tonometer. The Figure 4.5 shows that 
if a device of initial size less than 5mm3 were to be implanted in the eye, then IOP could 
be raised by making the device expand to 65mm3 instantly. The symbol Tv on  
represents the time for which the change in volume is maintained in the simulation. 
 
Thus, it has been demonstrated that the first requirement of monitoring Cf levels, that is, 
to raise IOP by 100% within the eye, could be achieved by reducing the internal eye 
volume by approximately 26%. The change in eye volume would have to be maintained 
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until the eye responded by reducing IOP to a starting level for the measurement to be 
completed. 
 
4.2.1. 4 Energy required  
 
An estimation of the energy that will be required for instantly taking up 26% of internal 
eye volume is calculated in this section. 
 
The calculations are based on the pressure-volume work relation for an isothermal 
system as the volume reduction in the eye is assumed to be initiated at constant pressure 
where there is no exchange of thermal energy involved. The work that will be done to 
create the volume change is calculated using Equation 4.1 below. 
 
W =   - PΔV                                                   (4.1) 
 
 
As it is assumed that an internal structural would expand in volume and spend energy to 
reduce the effective internal volume of the eye, the value for the work done is given a 
negative sign. The energy that will be calculated is for the time taken to initiate a 
volume change until  IOP rises and stabilises.  
 
The values used in the simulation were as follows:  
P = IOP  = 15 mmHg  
ΔV  = eye volume reduction /volume change end time -  
  volume change start time = one minute.  
 
Eye volume was reduced by 45 mm3, 55 mm3 and 65 mm3 respectively over one minute, 
with Cf = 0.30 mmHg/μl/min and Rigidity (K) = 0.15. The change in eye volume was 
carried out instantaneously and the energy consumed for every step reduction in volume 
observations was recorded in Figure 4.7. 
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Figure 4.6 Energy consumed vs eye volume change 
 
It was noted from Figure 4.6 that the energy consumed during a volume change in the 
eye increased along with the magnitude of the volume change. The energy that would 
be consumed by a 45 mm3 volume change was calculated to be 1.09e-5J, which 
increased to 7.5e-5J for 65 mm3 and to 0.00012J for a 75 mm 3 reduction in eye volume 
respectively.  
 
It was shown in Section 4.2.1a that in order to raise IOP by 100% inside the eye, the 
volume reduction would have to be equal to approximately 65mm3. The energy required 
to reduce internal eye volume by 65 mm3 would be 7.5 e-5J. This value only provides an 
indication of the energy that will be required to create the change in volume inside the 
eye.  
 
The total energy required to conduct the measurement will depend on forces that will be 
required to keep the volume change in place until the measurement is completed which 
depend upon the type of actuator that would be employed for the purpose and its 
physical characteristics. As the characterization of an actuator is outside of the scope of 
this thesis, the total energy required for the measurement is not calculated here. 
 55
However, a brief introduction to the type of miniature actuator that could be used for the 
volume change is provided in Chapter 7 (refer to Section 7.2). 
 
 
4.2.2 Requirement to measure IOP  
 
The following simulations were conducted to analyse the effects of measuring IOP 
inside the eye after raising it by 100%. The requirements of a miniature sensor that will 
be capable of measuring IOP internally will be brought forward by the investigations 
presented in this section. 
 
4.2.2.1 Sensitivity of Pressure sensor 
 
It was found in Section 3.3 that during external measurements, a difference in the level 
of Cf in the eye served to indicate an increase in the severity of glaucoma. The 
following simulation was conducted to determine the kind of pressure information that 
will need to be recorded by an internal sensor. The values used in the simulation are as 
follows:     
                                     IOP = 15 mmHg,  
   Rigidity (K) = 0.15 
   Decrease in eye volume = 65 mm3  
 
The IOP fall was recorded immediately after starting the volume reduction. The value of 
outflow facility was decreased from 0.30mmHg/μl/min to 0.15mmHg/μl/min to study 
its impact on sensor activity. The results are recorded in Figure 4.7 below.  
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Figure 4.7 Indication of time for recording IOP fall 
 
 
The legends Cf1 = 0.15mmHg/μl/min (poor), Cf2 = 0.22mmHg/μl/min (mildly low) and 
Cf3 = 0.33mmHg/μl/min (normal), represent typical levels of outflow facility in the eye. 
The symbol IOP fall max indicates the time during which there is maximum fall in IOP. 
 
It can be seen from Figure 4.9 that eyes with smaller Cf values show a slower rate of fall 
of IOP. The fall per minute of IOP for an eye with normal outflow facility, Cf = 
0.33mmHg/μl/min denoted in the figure by the green curve is quicker than the fall per 
minute observed in an eye with poor outflow facility, A = 0.15mmHg/μl/min, that is 
denoted by the red curve in the same figure.  
 
Thus, it can be observed from the simulation that the fall of IOP for an eye with very 
poor outflow facility was less than 1 mmHg per minute (from 31 mmHg to 30 mmHg) 
and was up to 5 mmHg per minute for an eye with normal outflow facility (30 mmHg to 
26 mmHg). It is noted that the IOP fall in the first minute of the simulation was 
comparable to the clinical values recorded by other glaucoma researchers [24]. Thus, for 
a pressure sensor to be sensitive to changes in Cf values, it should be capable of 
recording the fall of 1mmHg of IOP over one minute. 
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The symbol Pressure fall max in Figure 4.7 represents the time of the maximum rate of 
fall of IOP. If a sensor could produce an output such that the difference in the rate of fall 
of IOP can be detected, then it could provide an indication of the level of glaucoma in 
the individual’s eye. The simulation demonstrates that the sensitivity of the sensor 
would have to extend between approximately 1mmHg/min to 4mmHg/min.  
 
4.2.2.2 Alarm levels  
 
From the results presented in Figure 4.8, it can be inferred that if the pressure 
information from the sensor were to be processed electronically to calculate the rate of 
fall of IOP, then an alarm indicating the level of Cf can be issued to alert a patient to the 
change. Figure 4.10 below shows the potential alarm conditions for a glaucoma patient 
based on the simulation results.  
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Figure 4.8 Alarm Indication 
 
If the rate of fall was calculated to be less than 1mmHg/min, it would indicate a 
severely low level of Cf (alarm max). Rates closer to 2mmHg/min would indicate a mild 
decrease in Cf  (alarm med) and fall rates of 4mmHg/min or more would indicate a 
normal Cf level (no alarm). The alarm levels could provide an instant indication of the 
condition to the patient after processing the IOP information.  
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Thus, it has been demonstrated that in order to monitor Cf levels by measuring the rate 
of fall of IOP, a pressure sensor with a resolution of 1mmHg would be required.   
 
    
4.3 Schematic of a MEMS glaucoma monitoring device 
 
A schematic representation of a MEMS device that can monitor glaucoma from inside 
the eye can be drawn from the results of the investigations undertaken in Section 4.2. 
Figure 4.9 below illustrates the location of the inside the anterior chamber of the eye. 
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Figure 4.9 Location of Device inside eye. 
 
 
It was determined that if a device were to be employed for internally raising IOP by 
100%, its dimensions should be equal to 4×4×4mm or approximately 65mm3. The 
device could increase from a minimum size (less than 5mm3) to 65mm3 so that it could 
remain implanted without affecting IOP levels outside of measurement times. It has 
been calculated that the space taken up by the 65mm3 reduction in eye volume will be 
equivalent to taking up 26% of internal eye volume.  
 
An illustration of the proposed structure of the device during measurement is provided 
in Figure 4.10. It is assumed in the illustration that the fully expanded size of the device 
will not cover the pupil and not interfere with visual activity. Therefore, the size of the 
device before and during measurement will be suitable for implanting within the 
anterior chamber of the eye.  
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Figure 4.10 Schematic of Structure of Device and Sensor 
 
 
 
4.3.1. Discussion  
 
Figure 4.10 shows that the device could possibly have fixed and movable ends both 
attached to a material with elastic capability, which will allow for the increase in size 
required for measurement. The increase in the size of the device would have to be 
maintained until a sensor recorded the rate of fall of IOP (shown in Figure 4.9) and the 
measurement completed.  
 
The energy that will be required to create the volume change inside the eye was 
calculated to be 7.5e-5J. There has been the mention of thin batteries of 20mAh ratings 
(400μm thick) and micro-batteries with ratings of 100μAh/cm2 (< 10μm thick) that 
could be suitable for powering implants [72]. 
 
The thin batteries (400μm thick) that are currently available are large in size 
(2.5×2.9cm2). The micro-batteries (< 10μm thick) that may be suitable for implanting 
within the anterior chamber of the eye are still under development [72]. 
 
If it were assumed that a 100μAh/cm2 micro-battery were assumed to be used for 
powering the device, then the energy required for one measurement (7.5 e-5J) will be 
equal to draining 1.25μA of current per second from the battery. If it were assumed that 
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the time taken to conduct a test is approximately one minute, then it would be possible 
to extract 4,320 tests continuously from such a battery. This translates as being able to 
conduct one test daily for 11 years. Thus a portion of the powering requirements for the 
measurement could be met by available technology. 
 
4.4 Conclusion 
 
The feasibility of internally monitoring Cf by artificially reducing the eye volume and 
measuring the response of the eye in terms of rate of fall of pressure has been explored 
through the investigations conducted using a mathematical model of the eye. The details 
specific to the measurement method are thoroughly investigated in this chapter. The 
investigations have revealed that it will be possible to measure Cf based on IOP from 
within the eye. 
 
It has been determined analytically that IOP can be raised instantly by reducing the 
inner eye volume using a miniature device that can increase in size from 2×2×1.5 mm to 
4×4×4 mm. In order for the eye’s response to be captured effectively, the rate of fall of 
IOP in the eye will have to be recorded soon after the increase in device volume and the 
change will need to be maintained until a pressure sensor records the rate of fall of IOP. 
  
Based on the requirements of the device, it can be inferred that the mechanism suited to 
increase its volume and reduce the effective eye volume could be modelled as an elastic 
body with potential energy to which a pressure sensor could be attached to make the 
required measurements. The energy consumed by the measurement method can be met 
by currently available micro-batteries.  
 
The requirements specific to sensitivity and resolution of the sensor have been 
established through the investigations. The development of a suitable miniature pressure 
sensor required to accompany the glaucoma monitoring device will be explained in the 
next chapter. 
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5 Development of MEMS Pressure 
Sensor  
 
 
5.1 Introduction 
 
The need for a miniature pressure sensor was established in the previous chapter and its 
requirements were investigated. Based on those requirements investigations relating to 
the size, dimensions and the range of output voltages that will be obtained from such a 
sensor capable of sensing the rate of fall of IOP in an eye will be discussed in this 
chapter. 
 
5.2 Piezoresistive Pressure Sensing  
 
Piezoresistive pressure sensing technology facilitates the development of miniature 
pressure sensors that can be easily combined with simple signal conditioning electronics 
and are suitable for use along with implantable devices [73]. They have been reported to 
have the advantage of combining simple circuitry and small size of the sensing element 
with good sensitivity over capacitive pressure sensors which require reference pressure 
elements, complex signal conditioning circuitry and suffer from high electromagnetic 
interference [60].  The response time of these sensors has been measured to lie within a 
few milliseconds and their fabrication and packaging methods are very popular with 
industry. Therefore piezoresistive pressure sensing technology will be used in this 
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chapter to develop a MEMS pressure sensor that can be made small enough to be 
combined with a miniature device and monitor IOP. 
 
5.2.1 Theory 
 
Dr. Charles S Smith discovered the Piezoresistive effect in 1954 [74], the effect was 
defined as the change in resistivity of certain materials due to applied mechanical 
stress/strain. When a material experiences a strain due to an applied mechanical load, 
the strain varies the inherent resistivity of the material by altering the position and 
motion of the constituent atoms in the material. Silicon was discovered to possess 
excellent piezoresistive characteristics, twenty times larger than those of other metals, 
and has been used since 1974 to produce pressure sensors [75].  For a three dimensional 
silicon crystal, the electric field vector (ε) is related to the current vector (J) given by 
Equation 5.1 below where it can be seen that the electrical resistivity of a piezoresistive 
material is dependant on stress. 
 
ε = [ρ e + π + σ] . J                                                                (5.1) 
 
where 
ε   =   Electric Field vector 
J   =   Current Density 
ρ e   =   Resistivity Tensor 
π   = Piezoresistive tensor 
σ   =   Stress tensor 
 
Electrical connections made into the material enable conversion of the change in 
resistivity of the piezoresistive material into a measurable electrical signal. The 
mechanical and electronic properties of silicon enable the excellent conversion of a 
mechanical deformation into an electrical signal. 
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 5.2.2 Use of Piezoresistive Pressure sensors 
 
The first monolithic integrated piezoresistive pressure sensors were developed in the 
1970s and since then have found widespread commercial applications. C.C Collins 
proposed the feasibility of using a miniature transcutaneous pressure transponder [46] 
based on the piezoresistive theory, to be suited for biomedical applications. Though 
there have not been many reports of the use of piezoresistive pressure sensing for the 
development of IOP implants they are still very popular for industrial applications such 
as environmental monitoring, tyre gauge monitoring, barometric sensing, use in medical 
instrumentation and monitoring, pneumatic gauges, engine control and in home 
appliances. 
 
Very low range piezoresistive pressure sensors (0-0.75006 mmHg) are sold by a number 
of companies around the world. Figures 5.1 and 5.2 illustrate the front view and side 
view of the dimensions of a typical miniature pressure sensor. 
 
   
                                         
Figure 5.1   Front view of a miniature pressure sensor [76] 
 
 
The silicon membrane used for sensing pressure is usually a square as shown in the 
figure above and lies on the top face of the die. It is smaller in size than the die itself. 
Piezoresistors whose resistance changes with accordance to pressure applied on the 
silicon membrane are embedded onto it. The sensing elements and electronics are built 
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on the top side of the sensor, which is supported on either side by pedestals and 
sidewalls that form a part of the packaging. Figure 5.2 shows the typical dimensions of 
a low pressure piezoresistive sensor.  
 
 10mm 
 
 
       3mm
 
 
 
Figure 5.2 Side view of a miniature pressure sensor [76] 
 
   
From the above figures it can be seen that the dimensions of a typical low  pressure 
sensor are of the order of several millimetres and not suitable for implanting. Table 5.1 
lists some of the sizes and applications of a few commercial low pressure range 
piezoresisitive pressure sensors, available today.  
 
From Table 5.1 typical values for the size of a silicon die are found to range between 
650 µm and 25 µm. Few of these sensors are capable of measuring pressures in the 
range of 0 to few thousand mmHg [79], [76]. One of the smallest single chip absolute 
pressure dies available in the market, the SM5108 manufactured by SI Microsystems 
[79], measures 650×650×650 μm and has a range of 0-772 mmHg with a span of 
30mV.However, for the very low pressure range (0-375 mmHg) the size of the sensor 
die in the [76] and [77] sensors starts at 2.5 mm reaching up to 21mm with a span of 30 
mV.  
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Table 5.1- Commercially available low pressure piezoresistive sensors 
PRODUCT 
RANGE 
(mmHg) 
SPAN TYPE VIN APPLICATIONS 
SENSOR AREA (A) 
& THICKNESS (T)
RESPONSE TIME REFERENCE 
Mouser 1263 0-15 20 mV 
Differential/ 
absolute 
16V 
HVAC, Medical 
instrumentation, 
Environmental 
control 
A-27 mm by 12.2 mm 
T – N/A 
 
- [77] 
MPXM2053 0-375 40 mV Gauge 16 V 
Robotics, 
Pressure-Switching 
Controllers, Non-
Invasive pressure 
monitoring 
- 1 m Sec [78] 
SM-5108 0-772.56 35mV Absolute 5V 
Tyre pressure 
monitoring Engine 
control, Pneumatic 
gauges 
A - 0.65mm ×0.65mm 
T- 0.65mm 
- [79] 
Motorola X -
ducer 
750 40mV Absolute 5V 
Load, Level 
monitoring, Engine 
management, 
Personal blood and 
bedside pressure 
meters. 
A- 2.5×2.76mm 
T- 25 μm thick 
- [76] 
SM-5103 15-150 75mV Gauge 5 V 
Gas analysis, 
HVAC, level 
detection 
A-3.4mm×3.2 mm. 
 T -0.5mm 
- [80] 
 Thus it can be observed that when the pressure range is decreased then the size of the 
pressure sensor increases. The miniature low- pressure sensors documented in the 
literature have not been characterised to measure IOP [77], [80]. Information that will 
be required for the use of a very small membrane inside the eye like the size of the 
sensing membrane and the range of output voltages that can be obtained from it will be 
determined in the following sections of this chapter. 
 
 
5.3 Investigating reduction in size of sensor membrane 
 
In order to capture the physics of the problem, the calculations were based on finite 
element (FEM) analysis. FEM software, ANSYS (version 7) [81]was used to compare 
the theoretical predictions for load-deflection behaviour of thin membrane structures. A 
thin elastic structural element denominated as shell-63 in the ANSYS element reference 
library, having 8 nodes and three degrees of freedom was used to simulate the MEMS 
pressure sensor membrane.  
 
5.3.1 Sensor Deflection 
 
An analysis will be performed in this section to see how reducing the typical 
dimensions of a sensor membrane will affect its response. The response of a sensor 
membrane is measurable only if the deflections under applied pressure loads are well 
under the breaking limit of the membrane and are repeatable [82]. Silicon has been 
documented to produce repeatable deflection under an applied load, but when 
considering very small membrane dimensions, it needs to be investigated whether the 
deflections will be under the breaking range of the membrane. Figure 5.3 below shows 
how pressure will be applied uniformly across the surface of the membrane in the z 
direction.                                                                                            
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Figure 5.3 Top surface of square sensor membrane with side (a) and thickness (h) 
 
 
The size (a) of the sensor will be varied between 50µm and 400 µm and the thickness of 
the membrane will be varied at 0.1µm, 0.2µm, 1µm and 2µm respectively. The 
membrane will be subjected to IOP as surface loads each time. The range of pressures 
applied will fall between 15 mmHg and 48.754 mmHg that correspond to the range of 
15mmHg-50 mmHg. Investigations will be carried out using the linear- small deflection 
theory for elastic materials proposed in [83]. When it is considered that all the edges of 
a membrane will be clamped to ensure maximum response under load application, 
Timoshenko predicted that the maximum deflection for a fully clamped square structure 
could be calculated by Equation 5.1[84]. 
 
W max= ⎟⎟⎠
⎞
⎜⎜⎝
⎛ ××
D
aP 400126.0                           (5.1) 
where,  
                        
P =  Pressure applied           
h =  Thickness of the diaphragm                               
a =  Width of plate                               
D =  Flexural rigidity of the plate. 
 
For a square diaphragm, fully clamped on all four sides as shown in Figure 5.2 the 
flexural rigidity is given in [84]  according to Equation 5.1. 
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 D   = 
11
3Eh             (no units)           (5.2) 
 
where, the parameters used were, E (Young’s Modulus of Silicon) = 16.825×109 kg/m2. 
 
The deflections that would be obtained from the membranes were calculated 
theoretically using Equation 5.1 and verified using Finite Element Method Software 
(FEM) [85]. The results obtained from the software were within 1% of those predicted 
theoretically and are plotted in Figures 5.3 and 5.4. 
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Figure 5.3 Range of deflections obtained for different values of thickness (h). 
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 Maximum Deflection vs Pressure for different (a)
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Figure 5.4 Range of deflections obtained for different values of side (a). 
 
                              
5.3.2 Discussion 
 
From the analysis it was found that for a thickness h < 2 µm, the maximum deflections 
exceeded the thickness of the membrane. The horizontal dotted line in Figure 5.3 
indicates the points beyond which the deflections exceed the thickness of the 
membrane. Therefore only a diaphragm thickness of 2 µm produced deflections that 
were well under their thickness when subjected to surface loads in the IOP range. 
Reducing the size of the diaphragm below 400 µm produced deflections in the range of 
10-12 m upon application of IOP loads as seen in figure 5.4. As deflections in the range 
of 0.1×10-9 m can be more easily detected than deflections of the order of 10-12 m, a 
combination of a 400 µm wide membrane with a thickness of 2 µm is considered for 
further analysis. 
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Figure 5.5 range and pattern of deflections obtained on the surface of the membrane 
 
The figure 5.5 above plots the deflections from the centre of a membrane to its edge. 
From the FEM analysis it was determined that the deflections obtained was maximum at 
the centre (0, 0) of the membrane and was minimum at the edges. The results obtained 
were symmetrical along both the x and y axes.   
 
 Table 5.2 below lists the maximum deflection that will be obtained from the 
400×400×2 µm sensor under typical IOP loads.  As IOP in human eyes does not exceed 
50.5mmHg even under worst circumstances, it can be seen from table 5.6 that the 
maximum deflection from the sensor corresponding to that pressure can be seen to be 
less than 50% of the membrane thickness. 
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 IOP 
(mmHg) 
Maximum 
Deflection (m) 
5.7 × 10-715 
18.75 7.1× 10-7
24.75 8.9× 10-7
30 1.1× 10-6
34.50 1.2× 10-6
37.50 1.3× 10-6
41.25 1.8× 10-6
45 1.7× 10-6
50.25 1.8× 10-6
 
Table 5.2 IOP and corresponding values of maximum deflection 
 
 
The overall size and thickness of the sensor are reduced by 250 µm and 600 µm 
respectively. The range of deflections obtained for a membrane of these dimensions 
when subjected to IOP loads were between 0.07 µm and 1.8 µm. Therefore we can 
conclude that a smaller square sensor membrane of dimensions 400×400×2 µm will 
ensure a stable response under the IOP range that needs to be monitored in glaucoma.   
 
 
5.4 Determining the Electrical Output from the Pressure Sensor 
 
As a first step towards determining an electrical output from the sensor, an analysis of 
the stresses that will be created on the sensor due to IOP loads will be studied using 
FEM software. The stress analysis will help to provide an understanding of the factors 
that will affect the placement and location of piezoresistors, which will play a major 
role in determining the electrical output from the sensor. 
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 5.4.1 Stress Analysis 
 
IOP is assumed to be applied uniformly over the x-y plane that deforms in the z plane as 
given in Figure 5.6 below.  
 
 
 
 
 
 
 
                                                                               
(y) 
            
 
          (0 0)
 
(x) 
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Figure 5.6 Silicon membrane with centre (0, 0), and direction (z) of pressure application 
 
 
The surface stresses are calculated by the software according to Equations 5.3 and 5.4 
below where Tx denotes in plane forces along the x axis, Ty denotes in plane forces 
along the y axis, t is the thickness at the midpoint of the element along the z axis, σx 
denotes surface stresses that will be output in the x direction and σy denotes the surface 
stresses that will be output in the y direction. 
                         
6
)botmid4top(tT xxxx
σσσ ++=                                                 (5.3) 
 
6
)botmid4top(t
T yyyy
σσσ ++=                                                   (5.4) 
 
The pattern of stresses obtained from the FEM analyses of the silicon micro-membrane 
were consistent with the Timoshenko’s predictions in [84] and are illustrated in Figure 
5.7 below. The regions of maximum stress along the transverse direction are depicted in 
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the figure. It can be seen that the stresses were maximum at the clamped edge centres 
and minimal at the unbound centre of the membrane.  
 
 
X
Y
                            
Figure5.7 Pattern of Stresses obtained on the sensor membrane (along transverse axis). 
 
 
The stress pattern was found to vary similarly for longitudinal stress along the y axis 
due to the symmetry of the membrane. This is illustrated in Figures 5.8 and 5.9, which  
depict the stress variation from the edge centre to the ends of the membranes along x 
(transverse  stress) and y (longitudinal stress) axes individually.  
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Figure 5.8 Pattern of stresses along x axis of the membrane 
 
 
 
 
Figure 5.9 Pattern of stresses along the y axis of the membrane 
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 The pattern of stress variation remained similar when the simulations were repeated for 
different IOP loads, with a noticeable increase only in the magnitude of the stress. The 
maximum stresses obtained along the longitudinal and transverse directions for the 
different IOP loads applied on the membrane are listed in table 5.2 below. The stresses 
were determined from the FEM analysis to lie between 18.4×104mmHg to and 61.4 
×104mmHg 
 
IOP (mmHg) 
σ xx max 
 (Pa) or  
(7×10-3 
mmHg) 
σ yy max 
 (Pa) or 
(7×10-3 
mmHg) 
7.5 1.4×1010 1.37×1010
15 2.5×1010 2.46×1010
22.5 3.3×1010 3.28×1010
30 4.1×1010 4.09×1010
37.5 5.73×1010 5.73×1010
45 6.55×1010 6.55×1010
52.5 8.19×1010 8.19×1010
                                              
Table 5.3 Stresses obtained on sensor as a result of IOP loads. 
 
where, 
 
σxx   max      =       Maximum edge centre stresses along x axis    
                              
σ yy   max      =   Maximum edge centre stresses along y axis 
 
From Table 5.2 it can be observed that the stresses along the transverse and longitudinal 
axes are similar in magnitude.  As the stress created under the maximum IOP load of 
50.25 mmHg was found to be 61.4 ×104mmHg, it led to the interpretation that the stress 
magnitude would be under the 22.5 ×106 mmHg - 60×106mmHg, breaking limit of 
silicon [77]. Thus the pattern and magnitude of stresses that will be created as a result of 
IOP loads have been determined from analysis. It can be stated that a silicon membrane 
having dimensions 400×400×2 µm can withstand IOP loads. 
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5.4.2 Wheatstone Bridge and   Piezoresistors 
 
A Wheatstone bridge circuit configuration is traditionally used to derive an electrical 
output from a piezoresistive pressure sensor [60]. A typical Wheatstone bridge circuit is 
illustrated in Figure 5.10 below. 
 
 
 
 
 
 
      
                          
+
- + Vo   - 
 
 
R
 
 
 
 
R
 
3 
4 
 
 
R2 
 
 
R1 
 
Vs
 
Figure 5.10 Wheatstone -bridge network 
 
In the circuit four piezoresistors are connected to each other as shown in the figure 
above. A input voltage Vs is applied and an output voltage Vo is measured where output 
voltage is related to the input voltage by Equation 5.5 
 
 
V o    =   ( ) ( )⎥⎦
⎤⎢⎣
⎡
+×+
×−×
4231
4231
RRRR
RRRR
V                                                (5.5) s
)
 
The values of the piezoresistors are taken such that R1 = R3 and R2 = R4, this condition 
will ensure that that the offset output voltage in the unstressed state of the resistors be 
zero. Equation 5.5 then simplifies to Equation 5.6,  
 
 V o    =   ( ⎥⎦
⎤⎢⎣
⎡
×
−
21
2
22
1
4 RR
RRV                                                                 (5.6) s
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 The stress dependence of the resistivity of a piezoresistor is expressed in Equation 5.7 
 
               dR/R =   σ1π1 + σtπt                                                               (5.7) 
 
When the piezoresistor is subjected to a longitudinal stress σl and transverse stress σt, 
then there is a fractional change in resistance due to the piezoresistive effect. Here, π1= 
Longitudinal piezoresistive coefficient and πt = Transversal piezoresistive coefficient. 
The piezoresistors are taken to be oriented along the [110] direction of a (100) silicon 
wafer .The values for p-type silicon piezoresistive coefficients are considered in this 
thesis as they have been noted to have a larger sensitivity when compared to n-type 
silicon piezoresistors. The values for p-type piezoresistors are tabulated in Table 5.3 
[77]. 
 
 
 π11 10-11Pa-1 π22  10-11Pa-1 π44 10-11Pa-1
p-type 6.6 
 
-1.1 138.1  
 
Table 5.4 Piezoresistive Coefficients for   p- type silicon[77]. 
 
The piezoresistive  coefficients of the resistors are calculated by Equations 5.8 and 5.9 
 
π 1   = ½ (π11 +π22   +π44)                                                                                                              (5.8) 
 
π t   = ½ (π11 +π22   -π44)                                                                                                                 (5.9) 
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 The output voltage is obtained by differentiating Equation 5.7 with respect to R1 and R2 
given by 
 
ΔV o    =   ( ) ( ) ( )22211 112 r
r
R
dR
R
dRVs +⋅−⋅⎥⎦
⎤⎢⎣
⎡ +× η                                   (5.10) 
                   
                         where,   r =  
2
1
R
R      and   
⎪⎪⎭
⎪⎪⎬
⎫
⎪⎪⎩
⎪⎪⎨
⎧
+
+
=
2
2
1
1
11
1
R
dR
R
dR
η  
 
The term η in equation 5.10 causes the output to become non-linear, therefore in order 
to maximise V out the effect of η must be made neglibile. Maximising the magnitudes of 
dR1/R1 and dR2/R 2 in equation 5.7 can do this. Maximum fractional change in 
resistance in response to applied loads can be achieved by placing the piezoresistors in 
the regions of maximum stress on the membrane. The stress analysis conducted in 
section 5.3 (refer Figure 5.7) indicates that the maximum stress zones on a piezoresistor 
surface due to IOP loads are concentrated along the edge centres of every side of the 
membrane. The choice of locations is shown in Figure 5.11 below.  
 
 
 
Figure 5.11 Illustration of resistor placement in a bridge network [77]. 
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 If the piezoresistors could be located at positions along where the variation in stresses 
along both their longitudinal and transverse axes is minimum then maximum output 
voltage can be obtained from the sensor.  
 
The stress profile of the regions under maximum stress is studied to analyse the impact 
of the effect of longitudinal, transverse on those areas to determine any disruption that 
can be caused to the response of a resistor.  
 
The variations in stress along the transverse and longitudinal directions are plotted in 
Figures 5.12 and 5.13 below. It can be seen from the trends plotted that the maximum 
longitudinal stress is concentrated along a distance measuring less than 0.1μm and the 
maximum transverse stress is concentrated across a distance measuring less than 1 μm.  
 
 
 
Figure 5.12 Longitudinal stress variation along x axis at max IOP 
 
The figures show that there is sharp variation in stress values in both the areas. 
Although the maximum stresses are spread across very small distances it can be noted 
from Figure 5.7 that stresses of lower intensity extend around the edge centers. 
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Figure 5.13 Transverse stress variation along x axis at max IOP 
 
Thus from the results it can be conclude that if the stresses along the length and width of 
a piezoresistor will vary greatly when placed along regions of maximum stress on the 
membrane. The difference in average stresses along R1 and across R2 will cause the 
fractional change in resistance (dR1/R1 and dR2/R2) to be unequal. This non uniformity 
in stress will cause a reduction in output voltage.  
 
In order to nullify the effect of difference in fractional change in resistance the average 
of stresses at 5 points along the expected length and width of both the resistors are 
calculated. The length of the resistor is assumed to be 10 μm and the width is assumed 
to be 5 μm. The distribution of the points across the area of the resistor is shown in 
Figure 5.14. 
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Figure 5.14 Stress averaging locations on a resistor. 
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 The stress analysis was repeated for different IOP loads. The average fractional change 
in resistance (dR/R) avg was determined by averaging the values obtained for fractional 
change in resistance along the dimensions of each resistor (refer Equations 5.6, 5.7 and 
5.8).   
 
5.4.3 Discussion 
 
The values obtained for the average fractional change in resistance (dR/R) avg for 
different uniformly applied IOP loads are presented in Table 5.4 . 
 
IOP 
(mmHg) 
dR1/R1 avg dR2/R2 avg
7.5 8.5 -5.8 
15 12.8 -9 
22.5 16.8 -12.8 
30 22.3 -15.9 
37.5 25 -18.4 
45 32 -35.4 
                            
Table 5.5 (dR/R) avg values for different IOP loads. 
 
The change in resistance alters the balance of the Wheatstone bridge and produces an 
output voltage given by equation 5.10. The value for η is calculated using (dR/R) avg   
values. Typical values for input voltage are taken at 3V and the values of R1 and R2 are 
taken at 5 kΩ and 1.5 kΩ respectively [79]. The values for (ΔVout/Vin) are plotted for 
different IOP loads in Figure 5.16 below. 
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Figure 5.16   Output voltages that will be obtained for IOP loads 
 
From Figure 5.16 it can be seen that the electrical output from the MEMS sensor will 
varies linearly with the change in IOP and will be capable of detecting IOP loads (15-
40mmHg) where 1mmHg = 0.133 kPa. The sensitivity of the piezoresistive pressure 
sensor (mV/V/kPa) is calculated by dividing the change in output voltage over input 
voltage (ΔVout/Vin) by the applied uniform IOP and the results are plotted in Figure 5.17 
below. 
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Figure 5.17  Sensitivity of the Piezoresistive Pressure Sensor. 
                                 
The calculations demonstrate that voltages between 1.50 mV and 1.70 mV will be 
indicative of IOP changes inside the eye. The average sensitivity of the MEMS pressure 
sensor has been calculated to be 0.254 (mV/V/kPa) which is comparable to the output 
obtained for miniature pressure sensors in literature [86]. However the dimensions of 
the sensor developed to measure IOP are smaller and the pressure range considered 
much lower than of those considered in literature. The theoretically optimal MEMS 
sensor dimensions to monitor IOP are listed in Table 5.18. 
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Range 15mmHg –50.25mmHg 
Membrane – width & length 400  μm,400  μm 
Membrane thickness 2      μm 
18.4×104mmHg to and 
61.4 ×104mmHg 
Maximum stress 
Maximum Deflection 0.53 μm -1.76 μm 
Resistor length and width 20 μm, 5 μm 
Resistor values 5kΩ and 1.5kΩ 
Out put Voltage 0- 0.56 mV 
Input Voltage 3V 
                                                         
Table 5.6 MEMS Piezoresistive Pressure   sensor data 
 
 
It has been theoretically determined that the linearity of the sensor will not vary as the 
deflections remain small and linear for the given pressure range. The maximum stresses 
lie between 18.4×104mmHg to and 61.4 ×104mmHg. The maximum tensile stress that 
silicon can be subjected has been documented in literature [5] to be between 22.5 ×106 
mmHg - 60×106mmHg.  As the maximum stresses at P max are only in the 104mmHg a 
range, the sensor will not fracture under the applied pressure loads.  Due consideration 
should be given for any reduction in magnitude of the output of the sensor which may 
arise due to packaging and fabrication constraints.  
 
It was determined from previous investigations that the resolution of the sensor should 
be 1 mmHg. As it has been demonstrated that the sensor will be able to produce a 
detectable output for IOP loads less than 1 mmHg, it will be well suited to detect a 
decrease the Cf levels of the eye. The performance of the sensor will be tested and the 
results will be presented in a following chapter. 
 
 
 85
 5.5 Conclusion 
 
The size, deflection and output voltages of the MEMS piezoresistive pressure sensor 
that can monitor IOP have been calculated after investigation. The location of 
piezoresistors on the surface of the sensor that will provide the extraction of maximum 
sensitivity of the sensor were determined by analysing the patterns of the surface 
stresses of the sensor in response to IOP as a load.  
 
It was found that reducing the width and thickness of the diaphragm affected the 
pressure-based deflection obtained from the miniature sensor. The maximum range of 
stresses obtained under the operating pressure fell under the breaking limit of Silicon, 
thereby eliminating the issue of fracture. A Wheatstone bridge combination could be 
used to detect an output produced from embedding piezoresistors on the locations 
determined on the surface of the membrane. The output voltages that could be obtained 
from the miniature sensor would be between 0-0.56mV. 
 
Thus it will be possible to conclude that a miniature sensor of adequate size, sensitivity 
and resolution can be used to measure IOP in the eye. The feasibility of developing a 
MEMS piezoresistive pressure sensor that is capable of sensing IOP loads in the eye to 
monitor glaucoma has been presented in this chapter. 
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6 Testing of MEMS system  
 
 
6.1 Introduction  
 
In this chapter, a description of the working of the MEMS glaucoma monitoring system 
will be provided with the layout of the device and sensor, along with the powering and 
signal conditioning units. The system response will be tested under conditions of 
extreme outflow facility, rigidity and for cases where energy consumption can be 
minimised. The electrical outputs that will be obtained from the pressure sensor in 
response to different glaucoma conditions will be presented at the end of the chapter.  
 
6.2 Schematic of the MEMS glaucoma monitoring system 
 
Based on the investigations undertaken in this thesis, a schematic representation of the 
MEMS implantable glaucoma monitoring system is provided in Figure 6.1 below. The 
requirements of a device and pressure sensor were determined from Chapter 4 and a 
structural representation was presented (refer Figure 4.12). The development of a 
suitable miniature pressure sensor was undertaken in Chapter 5. The schematic 
representation of the entire system includes the powering, transmission and signal 
conditioning units along with the device and sensor. 
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 6.2.1 Description of layout  
 
The functional requirements of the monitoring system have been established through the 
investigations undertaken and presented in the earlier chapters of this thesis.  It was 
determined that in order to measure an increase in the level of glaucoma in an eye, the 
system should be able to detect a decrease in Cf values. From the work done in chapter 
4, it can be seen that this could be realised by using an expandable micro device which 
can increase in size from 2×2×1.5 mm to 4×4×4 mm, to temporarily raise IOP by 100% 
and employing a pressure sensor to measure the fall of IOP over several minutes. 
 
Figure 6.1 provides an illustration of the main components of the MEMS monitoring 
system. The device and the pressure sensor combined with the power source would 
form the major components of the implantable unit.  
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The device would have to be able to expand and reduce eye volume by approximately 
26% and hold the change over a period of several minutes for the measurement to be 
completed. The pressure sensor should begin to measure IOP soon after the change in 
eye volume. The signal conditioning unit should process the rate of fall of pressure and 
relay an alarm signal to an external readout or visual display unit through the 
transmission chip. The transmission and signal processing electronics could be included 
on the implantable chip with the device and sensor or left as external elements as 
indicated in the figure to suit any size constraints. 
 
6.2.2 Signal conditioning  
 
An illustration of an existing signal conditioning unit designed for use with a MEMS 
pressure sensor is shown in Figure 6.2 [56]. Such a signal conditioning unit would help 
to process, decode and digitise the required pressure information. Micro-processor 
based pressure to frequency converter modules are incorporated along with amplifiers 
and filters into the sensor chips for converting the pressure information obtained from 
the sensor into a transmissible form [87]. The converter modules are equipped with 
CMOS electronics based signal conditioning units as shown in the illustration.   
 
 
Figure 6.2 Existing signal conditioning circuit for a MEMS pressure sensor [56]. 
 
Similar systems with timers and clocks could be developed for integration along with 
the sensor to determine the rate of fall of IOP and trigger alarms when required. 
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Amplifier circuits are used along with piezoresistive pressure sensors to amplify the 
voltage output that is usually in the range of 10-3  to 10-6  Volts [88]. 
 
6.2.3 Powering and data transmission 
 
Powering could be undertaken using commercially available micro batteries or using RF 
based wireless transmission units [62], [73]. Battery-less powering is preferred for use 
in biomedical implants as it would remove the need to recharge and reduce the risk of 
contamination presented by the presence of a battery but will need a separate 
transmission system to accompany it [58]. 
 
However, if a wireless powering unit were to be used it could be coupled with a data 
transmission system and implemented either as a transcutaneous or an embedded 
system. In RF wireless powering systems, an external primary coil driven by a DC 
current source is used to transfer power to an implanted receiver coil via magnetic field 
coupling, where the receiver coil and transmitting antenna are attached to the sensor 
system on the implant [61]. The pressure sensor used along with such systems is usually 
a capacitive pressure sensor and the configuration is illustrated in Figure 6.3 below. 
 
 
 
 
Figure 6.3 RF based inductive coupling for wireless transmission [89] 
 
Wireless transmission of pressure data from piezoresistive pressure sensors used in 
implants have been recorded to transmit data up to a distance of a few metres with the 
use of RF inductive coupling [90]. The power supply used to power these implantable 
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units has been quoted in the literature to have a rating of 135 mV and power 
consumption of 65 µW [91]. Therefore, they pose only a minimal threat to the 
biological system in which they are housed. Alternatively, sufficiently rated micro-
batteries could also be used to power and transmit IOP data from the implant to an 
external device.  
 
6.3 Testing system response 
 
A mathematical model is used in this section to study the response that will be obtained 
if a miniature device capable of expanding were implanted (refer Figure 4.12) to reduce 
eye volume. It was determined from investigations (refer Section 4.2), that the initial 
size of an implantable device should be kept less than 5 mm3 so that it does not interfere 
with IOP levels at times other than the measurement. The IOP curve that will be 
obtained when eye volume is reduced by expanding a device instantly from 5 mm3 to 65 
mm3 is tested using the model under the potentially worst operating conditions inside 
the eye.  
 
6.3.1 Worst case conditions 
 
For a device with initial size less than 5 mm3 increasing in size to 65 mm3, the rise in 
IOP for eyes with severely low outflow facility (Cf = 0.15mmHg/μl/min) and normal 
rigidity ( K = 0.15)  appears to be as outlined in Figure 6.4. The total test time is 
assumed be 10 minutes and the volume of the device is assumed to increase within one 
minute of starting the test. The simulations were repeated with the initial IOP set at 15 
mmHg and at 25 mmHg to study the responses that would be obtained under normal 
and high starting points respectively. The symbol don in the Figure represents the time 
for which the device was turned on inside the eye during the simulation. 
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Figure 6.4 Comparing IOP measurements for severely low C f value  
 
 
It can be observed from Figure 6.4 that upon increasing the device size in eyes with 
very low Cf values causes the IOP to rise by nearly 100% and then falls off almost 
instantly, stabilizing at a few mmHg above starting level irrespective of the difference in 
starting IOP. The output obtained from the model when a device is used to reduce eye 
volume in eyes with severely low Cf   is similar to that obtained for eyes with normal Cf 
levels (refer to Section 4.2). 
 
The results obtained when a device with initial size less than 5 mm3 increases in size to 
65 mm3 implanted inside an eye with abnormally high rigidity (K = 0.45) and very low 
outflow facility (Cf =0.15mmHg/μl/min) is recorded in Figure 6.5 below. The total test 
time is assumed be 10 minutes and the volume of the device is assumed to increase 
within one minute of starting the test. The simulations were repeated with the initial IOP 
set at 15 mmHg and at 25 mmHg to study the responses that would be obtained under 
normal and high starting points respectively.  
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Figure 6.5 Comparing IOP measurements for very high K value 
 
 
It can be seen in the Figure above that the expansion of a device inside an eye with very 
high rigidity causes IOP to rise by approximately 200% for both cases of IOP starting 
levels.  
 
6.3.2 Discussion 
 
The responses obtained from the simulation demonstrate that the rise in IOP obtained 
when the test will be conducted in eyes with very low outflow facility and very high 
rigidities is much larger than the typical values (refer to Section 4.2). Most glaucoma 
patients could suffer from either low outflow facility or high rigidity. This could lead to 
a high rise in IOP during measurements which could expose patients to the risk of 
permanent blindness [63].  
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6.4 Effect of reducing device size  
 
6.4.1 Smaller device size  
 
An attempt was made to limit the extent to which IOP would rise, to reduce the risk to 
patients with high rigidity and low outflow facility during measurements. It was found 
in the previous section that a smaller device size could lead to a lower rise in IOP. 
Therefore, increasing device size from 5mm3 to 45 mm3 based on a mathematical 
model, was tested for an eye with very low outflow facility (Cf = 0.15mmHg/μl/min) 
and very high rigidity (K = 0.45). Initial IOP was set at 15 mmHg in the model. The 
results from the simulation are shown in Figure 6.6 below.  
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Figure 6.6 IOP rise with smaller device size (45mm3) 
 
It can be seen from the figure above that when size of the device size was increased to 
45mm3 when compared to 65 mm3, IOP rose by approximately 50% as opposed to 
100% in previous cases (refer to Section 6.3)  
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6.4.1.1 Detecting difference in Cf values 
 
The impact of having a smaller rise in IOP on detecting a difference in Cf levels was 
studied by running the above test in eyes with different Cf values, where:  
 
Cf1 = 0.15 mmHg/μl/min (poor),  
Cf2 = 0.22 mmHg/μl/min (mildly low) and 
Cf3 = 0.33 mmHg/μl/min (normal)  
 
represent the typical levels of outflow facility in a human eye. The simulation was 
repeated for normal (K = 0.15) and very high (K= 0.45) values. The results from the 
simulation are presented in Figures 6.7 and 6.8. The symbol Press diff in the figures 
denotes the times during which there is a difference in the rate of fall of IOP. 
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Figure 6.7 Sensitivity to Cf with smaller device size with k= 0.15 
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Figure 6.8 Sensitivity to Cf with smaller device size with k= 0.45 
 
 
6.4.1.2 Discussion 
 
It can be seen from Figure 6.7 that when a smaller device size is used in an eye with 
normal rigidity (K = 0.15), there is hardly any difference in the rate of fall of IOP. 
However, it is observed from Figure 6.8 that if a smaller device size were used for 
measurement in an eye with high rigidity (K = 0.45) there is a difference of 
approximately 2 mmHg in the rate of fall of IOP during the first minute of the test.  
 
 
6.4.2 Optimal Device size 
 
As using a device size of 45 mm3does not show a difference in the rate of fall of IOP in 
a normal eye (refer Figure 6.7) this size may not be suitable for measurement purposes. 
Therefore, a slightly larger device size (55 mm3) is used in the next simulation. The 
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value of rigidity is set as normal in the simulation (K = 0.15) and initial IOP is set at 15 
mmHg. The simulation was repeated for different Cf values and the results are presented 
in Figure 6.9. 
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Figure 6.9 Sensitivity to Cf with smaller device size (55mm3) device size with K= 0.15 
 
 
It can be seen from the figure above that the rise in IOP is approximately 67% when a 
device of size 55mm3 is used in the simulation. It can also be observed that there is 
detectable difference in the rate of fall of IOP in the first minute of the test. The fall per 
minute of IOP is 1mmHg per minute for poor Cf levels (Cf 1 = 0. 15 mmHg/μl/min) and 
is 3mmHg per minute for normal Cf levels (Cf 3 = 0.30 mmHg/μl/min). These values 
are similar to the ones obtained when 65mm3 was used to create the volume change 
(refer Section 4.2.2). 
 
As previously demonstrated in Section 6.4.1, repeating the test in an eye with normal 
rigidity will show a greater difference in the rate of fall of IOP.  
 
6.4.3 Discussion 
 
The measurement has been simulated for the worst case situations inside the eye. The 
results demonstrated that using a device of 55mm3 approximately, would result in a safe 
Maximum IOP 
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rise in IOP in eyes with low outflow facility and very high rigidity. Using a device of a 
smaller size would not allow detection of a difference in the rate of fall of IOP and 
using a device of a larger size could be potentially harmful to patients. 
 
It was calculated that using a 55mm3device size for the measurement will consume 
3.82e-5J of energy (refer Section 4.2.1). The percentage of eye volume that is taken up 
by the device during measurement was calculated to be approximately 22%. However, 
the energy consumed and the space taken up inside the eye is less than that calculated 
for 65mm3 (7.49 e-5J and 26% respectively) in Chapter 4.  
 
 
6.5 System output with optimal device size 
 
It was determined in Chapter 4 that the sensor would be required to have a resolution of 
1mmHg to detect a difference in Cf levels (refer Section 4.2.2). It was subsequently 
determined in Chapter 5 that a MEMS piezoresistive pressure sensor could produce a 
voltage output corresponding to every mmHg fall in IOP (refer to Section 5.4, Figure 
5.16).  
 
The electrical output that will be obtained from the miniature piezoresistive pressure 
sensor, when it is included with the device, is calculated using the mathematical model. 
The legends represent typical levels of outflow facility in the eye: 
 
Cf1 = 0.15 mmHg/μl/min (poor), 
 Cf2 = 0.22 mmHg/μl/min (mildly low) and  
Cf3 = 0.33 mmHg/μl/min (normal) 
 
Starting IOP is set at 15mmHg and rigidity is set at (K= 0.15) in the simulation to 
represent the typical values for a normal eye. The sensitivity of the sensor to differences 
in Cf levels is recorded from the model output and illustrated in Figure 6.10 below. 
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Figure 6.10 Voltage vs time for different Cf   levels. 
 
 
It can be seen from Figure 6.10 that there is fall in voltage output with time that 
corresponds to the difference in Cf levels. The symbol Volt diff max in the above figure 
indicates the time during which there will be maximum change in voltage in the 
sensor’s output. 
 
It was determined previously that for eyes with very poor outflow facility level (Cf1 = 
0.15mmHg/μl/min) the rate of fall of IOP is less than 1 mmHg/min. This corresponds to 
less than 1mV fall in voltage over time from the sensor for an eye with Cf1 in Figure 
6.10. Similarly, there is nearly a 2mV fall and 3 mV fall in voltage over two minutes for 
Cf2 and Cf3 respectively.  
 
From the range of the output voltages obtained, it can be inferred that approximately 
5μV/mmHg will have to be measured to detect a difference in the Cf levels of a person. 
An amplifier could be integrated with the pressure senor unit to amplify the voltage 
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output for processing and transmission purposes [60]. As the response time of 
piezoresistive pressure sensors has been reported to be in the 1 millisecond range, it will 
be capable of responding to IOP monitoring [77]. 
 
If a timer were to be integrated with a signal conditioning unit and sensor that could 
time the fall in voltage over a minute after the volume change, then an alarm could be 
triggered to indicate the level of severity of glaucoma in the eye (refer Figure 6.1). 
 
Thus, from the results of the simulation, it can be inferred that a detectable electrical 
output can be obtained from the MEMS monitoring system and be used be to indicate 
the presence of glaucoma in an individual’s eye. 
 
 
6.6 Conclusion 
 
An overview of the implantable glaucoma monitoring system along with the powering 
and signal conditioning units has been presented in this chapter. It has been 
demonstrated that a device of initial size less than 5 mm3 or (1×1×5mm) that can 
expand to approximately 55 mm3 or (3×3×6mm) could be used to monitor Cf levels 
from within the eye. The results demonstrated that such a device would raise IOP by 
67% above starting level during measurement.  
 
It would be possible to detect a difference in the rate of fall of IOP based on severity of 
glaucoma using a MEMS piezoresistive pressure sensor. The device has been 
successfully tested using the mathematical model for the worst case conditions in the 
eye.  
 
It was observed that the MEMS pressure sensor could be integrated with the device to 
detect the fall of less than 1mmHg/minute of IOP by a corresponding output voltage in 
millivolts.  
 
Using a smaller size device allows for a safe Cf based IOP measurement in eyes with 
severe glaucoma. The results have shown that a smaller device size allows for a 
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discernible detection of the difference in the rate of fall of IOP even though IOP is not 
raised by 100%. The results have shown that the output from the model would be 
similar to the pressure data that would be obtained when a tonometer is used to measure 
a difference in the Cf levels of a patient. It was observed that the sensitivity and 
resolution of the sensor were not affected by reduction in size of the device. This 
implies that the overall device size and powering requirements of the monitoring system 
could be minimised from the values determined initially in Chapter 4.  
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7 Review of Technology for 
Fabrication and Packaging 
 
 
7.1 Introduction 
 
The likely methods that can be used for the fabrication and packaging of the expandable 
device and pressure sensor of the glaucoma monitoring system will be discussed in this 
chapter.  Bio-compatibility and implanting issues will also be discussed. 
 
7.2 Device fabrication 
 
7.2.1 IPMC Theory 
 
It was previously determined previously in chapter 6 that a miniature device that will be 
capable of expanding from an initial minimum size (1×1×5 mm) to a size large enough 
(3×3×6 mm) to raise IOP temporarily in the eye will play the most important role in 
internal glaucoma monitoring. The device will reduce effective internal eye volume by 
expanding and maintain the change in size for the duration of the measurement which 
indicates that the device will have to have movable parts (refer Figure 4.12).  
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Ionic polymer metal composite (IPMC) materials have been found to be suitable for the 
development of miniature, low powered, biocompatible implants [92]. Due to their fluid 
based activation characteristics they could be considered as potential candidate 
materials for the development of the implantable glaucoma monitoring device. 
 
IPMC materials are a class of electrically active polymers that have the capacity to 
provide an actuation displacement of >3% with 10-30 MPa tip force under a driving  
voltage of 0.1-7 Volts [93]. This class of electrically active polymers requires a fluid 
medium to operate and has been cited to have the potential to be used in biomedical and 
glaucoma implants due to their superior electro-mechanical properties of low actuation 
voltage, low density and repeatability when compared to other micro actuators [94]. 
 
Studies so far have considered sample sizes 25×3×0.19 mm [94]. Almost all of the 
characterisations have been based on cantilever type arrangements of the sample with 
the governing Equation 7.1 given below [95]. 
 
δ = PL3/ 3EI                                                             (7.1) 
 
Where 
          δ = Deflection obtained 
         P = Applied point load 
        L =   Length of the strip 
        E =   Young’s modulus of the material 
         I =   Moment of Inertia of the material 
 
The material properties of these polymers are dictated by the presence of Li+, Na+ , K+ 
and tetra-butyl ammonium (TBA+) ions. When placed in a fluid medium, on the 
application of a supply voltage the positive ions in the polymer film move towards the 
negative electrode causing a change in the volume of the polymer film as illustrated in  
Figure 7.1. 
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                                      Figure 7.1   Deformation of an IPMC strip under applied electric field. 
 
 
The electro-mechanical response of these polymers is followed by relaxation owing to 
their ionic content. Analytical and electric macro models have been developed to 
characterise their response to applied electric potentials under a range of operating 
conditions [96]. 
 
It has been reported that IPMC strips can be developed with contractile, flexing, 
undulating and serpentine configurations [93]. Therefore the feasibility of reduction in 
size and related displacement characteristics of this class of materials needs to be 
investigated if intended for use in glaucoma monitoring systems. 
 
The fabrication of polymer based microstructures with movable parts has been 
undertaken using LIGA [97]. LIGA is a micro fabrication process that combines x- ray 
lithography, electro-forming and moulding techniques for the fabrication of micro-
structures with structural heights reaching several micrometers with varied shapes.  
The advent of this technology has enabled the development of micro-pumps with a 
flexible polyimide micro-membrane for applications in micro-fluidics. Several types of 
movable, stepped, slanted micro structures for use in micro-pumps, valves, nozzles and 
other micro-fluidic applications have been extruded and built using the LIGA technique 
[98]. 
Thus this particular fabrication process could be utilised for the fabrication of a 
glaucoma implant with an expandable volume while still being attached to the sensor 
and other digital electronics. 
 
 
           + -   +   -   +   -  +             
+   +                         +  + 
            - - - -  
          
Fluid Medium 
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 7.2.2 Fabrication  
 
 A LIGA micro-mould is combined with injection or reaction moulding techniques to 
create a microstructure specific to the application required. LIGA allows for electro- 
less plating and deposition of metal inserts into the polymers, whether they are of the 
shape hardening variety or are rubber/silicone like elastic polymers. The process 
sequence for preparing IPMC strips has been provided in [99]. A solution of the 
commercially available polymer film is prepared without any discontinuities or air-
bubbles. The solution is poured into a casting frame much like the procedure used to 
create rubber like elastic micro-structures using a high aspect ratio electro-deposited 
metal mould. The liquid solution is dried and thermally treated to increase the 
mechanical stiffness of the film. The film is boiled in hydrogen peroxide (H2O2) and 
water at very high temperatures of 75-100° C for an hour and prepared by boiling in de-
ionized water. The process is illustrated in Figure 7.2 below. 
 
 
 
Figure 7.2   LIGA fabrication process for polymer based microstructures [99] 
 
The film is plated with electrodes on both sides by an electro-less plating method. The 
electro-less plating method used in LIGA allows for shaping and manipulation of metals 
with the polymers during and after deposition.  
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Thus combining IPMC fabrication methods with a LIGA type set-up could lead to the 
production of the shape and size of the device required by the glaucoma implant. Finite 
element method (FEM) tools like ANSYS can be used to study the electromechanical 
response of this type of material as demonstrated in [100] 
 
7.3 Pressure Sensor Fabrication  
 
Bulk micromachining and surface micromachining are two of the methods widely used 
to fabricate micro pressure sensors [60]. During the process several steps are undertaken 
to fabricate the mechanical structures on a silicon wafer and deposit the electronic 
components that need to be combined with the sensor. Combining electronics with the 
sensor imposes limitations on the type of fabrication method being used. 
Polysilicon surface micromachining combined with a CMOS process has been 
recommended by various texts [75] for the fabrication of micromechanical 
piezoresistive pressure sensors. This combination enables the use of higher operating 
temperatures when compared to bulk-micromachining.  An illustration is provided in 
Figure 7.3. 
 
 
Figure 7.3 Surface micro machined pressure sensor [99] 
 
Using specially fabricated wafers such as SIMOX for fabrication reduces the number of 
process steps and allows for easy packaging of piezoresistive pressure sensors [99]. 
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 7.4 Packaging and Biocompatibility 
 
7.4.1 Packaging and Biocompatibility 
 
Micro-machine packaging protects the device from any harmful interactions with the 
surrounding environment. However it is also responsible for allowing the device to 
create changes to environment and for the sensor to measure the impact of physical 
parameters. In the case of the glaucoma monitoring device, the packaging should allow 
for change in size of the device as well as protect the device and sensor electronics from 
the fluid in the eye.  
 
Packaging could introduce extra strain and cause the final sensor performance to vary 
[101]. The issues of biocompatibility and waterproofing are of major concern in 
biomedical and ocular implants.  The material used for biocompatible encapsulation of 
the implants has been reported to be a medical-grade polymer, Nu Sil MED-2000 and 
MED-1511 [58]. Silane, silicone-elastomer materials are also used to package 
biomedical implants, due to their non-corrosive and inert nature. The elastomer 
packaging also serves to isolate the sensor and its associated structures from the 
surrounding environment by providing adequate water-proofing and offers protection 
against any electrical or chemical leakage from the implant. These commercially 
available polymers are used to seal the implants externally. A thickness of up to 20μm 
has been reported to be used for coating micro sensor structures, without compromising 
device output [58].  
 
The bio-compatible encapsulation intended for the glaucoma implant will have to take 
into consideration the presence of movable parts within the implant. The encapsulation 
will have to accommodate structural activity owing to the increase in volume of the 
device and still be able to provide sound waterproofing without interfering with the 
device output and sensitivity in a major way.  
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ANSYS simulations could be used to study the effects of packaging [101]. Hermetic 
sealing of bio-medical implants prevents contamination by body fluids. Studies have 
shown that hermetic sealing does not affect the performance of the implant [102]. 
 
7.4.2 Implanting 
                    
Great progress has been achieved with the technology that allows for successful 
implantation of medical implants. Minimally invasive surgical methods and 
microsurgery are often used to implant bio-medical ocular implants. Laser technology is 
used for surgical cutting and precise positioning of miniature implants in the eye [103]. 
The devices might require adjustment to suit individual patient requirements as the level 
of IOP has been documented to differ in individuals. Whether the device and sensor 
might need adjustment to suit an individual eye’s physical characteristics and IOP range 
could be a cause of concern with reference to large scale production of the device [104]. 
This requires further attention.  
 
One of the several problems that is often encountered after implanting the device is 
bleb-formation [54]. Additional tissue similar to scar tissue sometimes grows on ocular 
implants which could pose a serious issue by compromising device performance. 
Research needs to be undertaken to be able to overcome the effects of bleb-formation 
and scar tissue growth on the ocular implants to preserve maximum device output over 
a prolonged period of time. 
 
7.5 Conclusion 
 
A feasible method of developing and fabricating a MEMS device that will allow for a 
change in size within low activation energy limits to suit a biological system is 
presented. MEMS pressure sensor fabrication and packaging methods are discussed and 
the issues surrounding bio-compatibility and successful implanting of the device are 
included. Thus the feasibility of fabricating and packaging the device and pressure 
sensor of the MEMS glaucoma monitoring system have been presented in his chapter. 
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8 Conclusions and Further Work 
 
 
The aim of this thesis was to investigate the development of a MEMS glaucoma 
monitoring system. The literature review demonstrated the importance of a Cf based 
glaucoma monitoring system and it’s potential to forewarn the patient of a rise in IOP 
due to flow blockage in glaucoma. A mathematical model of the eye was used to study 
the effects of eye volume, rigidity and outflow facility on internal IOP measuremnet and 
the results were compared with tonometer measurements. The model was then used to 
conduct simulations to arrive at the requirements of an implantable glaucoma 
monitoring system. 
 
Based on the investigations performed, it was determined that an expandable device 
could be used to raise IOP temporarily in the eye and an indication of Cf levels could 
then be obtained by determining a difference in the rate of fall of IOP using a MEMS 
pressure sensor.  
 
The device size, measurement method and energy requirements were determined from 
investigations. The energy requirements have indicated that a major portion of the 
powering can be undertaken using either miniature batteries or other available 
technology and allow for daily tests to be conducted over a number of years. A suitable 
pressure sensor was developed to record the fall of IOP after introducing the volume 
change. The response of the system was tested for worst case conditions and the 
expected electrical output of the sensor was determined.  
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 Possible methods of powering the implant, providing data transmission and signal 
conditioning were also presented. An overview of the fabrication and packaging details 
of the device and sensor were discussed in the thesis along with implanting and 
biocompatibility issues. 
 
The theoretical basis for undertaking the development of a MEMS glaucoma monitoring 
system was established based on a survey of the existing literature and further 
investigation undertaken in this thesis. These investigations clearly demonstrate that it is 
possible to measure IOP continuously within the eye to indicate the onset or increase in 
the severity of glaucoma.  
 
The requirements of a MEMS device have been determined and a potential class of 
actuators has been nominated for undertaking its development. However, the 
mechanism, stiffness, shape of the device, the electrical activation required to support 
change in device size and the energy requirements of the entire measurement need 
further investigation. A standardised method of extracting Cf data from the measured 
rate of fall of IOP would need to be established.  
 
A prototype of the device would need to be built and tested in an environment similar to 
the eye to compare the output that will be obtained from it to the theoretical results. The 
packaging and fabrication of the prototype are required to be addressed and 
implemented.   
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A pressure conversion table from mmHg to kPa is provided here in the 
appendix for the convenience of the reader as the unit of IOP has been 
taken as kPa in the simulations and calculations in chapter 5. 
 
 
 
Pressure Conversion table 
IOP  IOP 
mmHg  kPa 
1  0.1333224 
5  0.666612 
10  1.3332239 
15  1.9998359 
20  2.6664478 
25  3.3330598 
30  3.9996717 
35  4.6662837 
40  5.3328956 
45  5.9995076 
50  6.6661195 
   
 
 
 
 
 
 
 
 
 
                                Table A1 Pressure Conversion Table                                                                      
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Development of a M E M S device to monitor Glaucoma
Smitha Shankar, J.P.  Chaffey
School of Electrical and Computer Engineering
RMIT University, GPO box 2476V
Melbourne, Victoria 3001, Australia.
ABSTRACT
    Glaucoma is one of the leading causes of blindness affecting millions of people worldwide. Regular monitoring of
intra ocular pressure (IOP) in the eyes is an important component in the treatment of this affliction. Current manual
measurements do not give room for continuous indication of the progression of the disease. Microelectromechanical
System (MEMS) technology lends itself to the development of devices capable of in-situ monitoring of the phenomenon
that occur at the micro and nano scales, inside the human body. The paper reports on the complex flow and pressure
relationships in the eye and the current methods of monitoring Glaucoma. The comparison highlights the requirements of
an implantable miniature device that can indicate the changes leading to an increase of IOP inside the eye. An analysis of
the pressures in the anterior chamber of the eye was undertaken to estimate the out put voltages that could be obtained
from a micro structure implanted in the eye.
Key words- Microelectromechanical systems (MEMS), Glaucoma, Intra ocular pressure, anterior chamber, human eye,
aqueous humor, pressure sensor, Finite element method (FEM) analyses.
1. INTRODUCTION
Glaucoma is one of the leading causes of blindness in the world. It is estimated that 6.7 million people, are blind
from glaucoma and about 70 million are suffering from the disease worldwide1. The disease occurs when the fluid
(aqueous humor) flowing continuously in the anterior chamber of the eye gets blocked, due to various pathological,
reasons2.  Once the flow gets blocked, intra ocular pressure (IOP) begins to rise steadily 2. Figure 1, below illustrates
the point of entry of the fluid into the anterior chamber,  from its site of production. The fluid enters through the
pupil, circulates through the anterior chamber, nourishing all the intra ocular contents . It then exits at the angles
where the cornea meets the iris via numerous exit channels, filters through a porous tissue called the trabecular
meshwork and finally drains back into the venous system.
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Fig1. [3] Illustration of the flows in the Eye
1.1Flows in the Eye
  There exists a delicate, but complex equilibrium between the fluid flow and pressures associated with eye4. The flow
rates into and out of the eye are balanced and maintained at 2.5-3 µl/min. IOP in the eye is measured at 15 mmHg
(1999Pa) normally3. When the flows into or out of the eye are obstructed, then the equilibrium is disturbed and the
pressures inside the eye begin to rise steadily, up to 40mmHg (3999 Pa). IOP, the pressure head in the anterior chamber
of the eye4, is the tissue pressure of the intra ocular contents also responsible for maintaining the shape of the eyeball. A
rise in IOP levels causes damage to the optic nerve resulting in blindness. Thus a shift in the complex flow pressure
equilibrium thus in high IOP. All the parameters relevant to glaucoma and high IOP are linked to one another as shown
in Fig 2.
Fig2. Inter-dependence of key factors in the Eye
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1.2 Key parameters in Glaucoma
The key parameters, for indication of glaucoma conditions are:
             Fin            =   Flow into the eye (micro litres/min)
                   
F out          =    Flow out of the eye (micro litres/min)
          ∆
 
P (IOP)
 
=   Intra ocular Pressure (mm/Hg) (pressure head in the anterior chamber)
           P inlet     =     Pressure at inlet (mm/Hg)
           P outlet   =    Pressure at outlet (mm/Hg)
                
R0=   1/c    =    Resistance to outflow/Outflow Facility ( micro litre/ min/mmHg)
   These  key parameters,  are related to IOP as shown  in   fig3.
                                                                   Fig3. IOP and the key parameters for glaucoma indication.
According to Adler’s text4 glaucoma is signified by an increase in the parameter, Ro, the resistance to outflow, measured
in µl /min/mmHg. An increase in R0 is accompanied by a decrease in the outflow (F out) of fluid. A decrease in outflow
triggers a simultaneous increase in both IOP, (∆P), and fluid production in order to maintain the net flow rate between
2.5-3 µl/min. The phenomenon of glaucoma is illustrated by referring to the graphs in fig4 adapted from4.
                                                          
     Fig4 [4]   Effect  of the key parameters in Glaucoma on each other
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From experiments and studies performed on enucleated human eyes reported in literature5,6,7, it is seen that during the
normal operation of the eye, the fluid inflow rate is estimated to be around, 2.5µl/min. The dashed curves falling to the
right in fig 4, represent fluid inflow rates. The resistance to outflow is measured to be 0.16µl/min/mmHg (Ro = 3 in fig
4). The solid lines in the figure, rising from the origin represent the resistance to outflow (Ro) range.  When Glaucoma
sets in the resistance to outflow (R0 =5, 6, 7 etc. in fig4), and the inflow rate increase (3µl/min in fig4). The outflow rates
are represented by the dashed lines rising from the origin in the figure. They fluctuate with change in resistance to
outflow. These set of curves represent the complex equilibrium in the eye. A steady rise in IOP, accompanies these
phenomenon. Currently, glaucoma is monitored; by measuring, IOP alone , from time to time (normally intervals of 3-6
months). Treatment is directed at the reduction of pressures in order to bring down the risk of optic nerve damage and
blindness. Since the frequency of monitoring pressure is low, a person with glaucoma has no indication of the likely
advancement of the disease, due to changes associated with the other key phenomenon relevant to the condition.
1.3 Current  external methods of monitoring Glaucoma.
  The current external methods of monitoring glaucoma, adopted clinically are discussed in this section. Once diagnosed
with glaucoma, the pressure levels and the  extent of blockage in the eyes are assessed at   regular intervals2 . Table1,
below categorises the types and functions of the different external methods adopted to monitor glaucoma, universally6,7.
METHOD SENSOR RANGE                   TYPES ACTION FUNCTION
Applanation
Tonometry
  Pressure
Sensor 0-40mm
Hg
A Goldmann, Mackay  Marg
Tonometer
B.  Malakoff &  Posner Tonometers
C. Automated Handheld Tonometers
Force required to
flatten a   constant
area on the CORNEA
measured.
 Assess extent
of block and
measure IOP
Indentation
Tonometry
Pressure
Sensor
0-50 mm
Hg
Schiotz Tonometer. Constant force applied
on cornea and depth of
indentation due to
pressure inside
measured
Assess extent
of block and
measure IOP
                                                      Table 1.  Current external methods of monitoring Glaucoma.
 The extent of the block to fluid flow and the steady state IOP level in the eye are determined by tonometry. Eyes with
glaucoma, are  treated by either suppressing the increased fluid production or decreasing the pressure at the outlet
channels of the eye2. Tonometers are, external probe like instruments impressed upon the eye, to artificially raise the
volume of fluid and pressure inside the eye and measure the time taken by the eye, to remove that extra fluid and
pressure. The rate of fall of pressure is measured as a decay of pressure over time and linked directly to the extent of the
block at the outlet channels6,7.  When the time taken for the pressure to decay is in excess of 25%/min, then it is
confirmed that glaucoma has set in7 . Efforts are under way to eliminate these laboratory type measurements for
glaucoma, which are discontinuous and sometimes painful, as they might require local anaesthesia6 . However, it is
observed that these
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methods may not able to indicate the onset of glaucoma in the eye and only aid in an assessment of the condition to
check further advancement.
2. OBJECTIVE
The present research is aimed at developing an implantable device, capable of indicating the onset of a block to the fluid
flow. The device requires to be placed in the anterior chamber of the eye to monitor the conditions leading to glaucoma.
In order to this, the device would have to be miniature in size so that it can  operate within a fluid volume of 250-260 µl5,
and IOP ranging between (12-30 mmHg). The device will have to able to alert the patient to an imbalance in flow rates, a
rise in (R 0), resistance to outflow, and a subsequent rise in IOP which are all the key parameters in glaucoma diagnosis
and treatment. An indication of this kind will enable the patient to take steps towards management of the disease. Though
an indication of this kind is currently unavailable to the patient, recent developments in micro electro mechanical
systems (MEMS) technology has given room for the development of miniature, medical devices that can replace external
measurements and provide continuous indications of internal biological activity8. MEMS, technology allows for the
sensing, actuating, and signal processing electronics to be available on the same implantable chip. Therefore, the
development of an implantable miniature device, capable of continuously monitoring glaucoma is undertaken using the
advancement in this technology.
2.2   MEMS   IOP sensors reported in literature
MEMS IOP sensors have been reported in literature from 1999, based on the pioneering work of Collins in 1969 9. Table
2 below compares the type s and functions of these sensors8,10,11,12,13
     SENSOR-
MECHANISM
DATA
TRANSMIS
SION
REFERENCE
PRESSURE
RANGE    TYPE OF IMPLANT
&SIZE
FUNCTION
Diaphragm
movement
Capacitive element
RF transmission
with on chip
antenna
Absolute
(measured
against
vacuum as
reference
pressure).
50-150
KPa
Implantable in the
Lens.
6.76mm2
Measurement of IOP
Diaphragm
movement-
Capacitive element
 RF transmission
with on chip
antenna
Absolute 50-150
KPa
Implantable in Lens-
with a silicone coating
6.25mm2
Measurement of IOP
Diaphragm
movement
Capacitive and
Piezo resistive
elements.
Not specified Absolute Not
specified
Not specified Measurement of IOP
Diaphragm
movement-
Capacitive Sensing
On Chip-
Frequency
transmission
Absolute 14-220
KPa
Not Specified. Measurement of IOP
Strain Gauge based
sensing
RF transmission
with on chip
antenna
None Strain gauge sensors
built onto a contact
lens
Measurement of IOP
                                          Table 2. Type & Function of MEMS IOP sensors reported in literature.
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The sensors listed in table 2, have been designed to measure IOP, (∆P) alone. They are not able to indicate the extent of
blockage in glaucoma or indicate the onset of a block as possible in the external methods for monitoring glaucoma. The
sensors8,10,11, 12 are designed to be, lens implants. On comparing the average size of the lens implants (6-8mm) and the
size of the human les (3-4mm transverse and 9mm,equatorial)14 it is seen that the reported implants is nearly the size of
the human lens and might obstruct the vision of the wearer. Thus, the reported miniature IOP sensors can monitor
changes in the pressures in glaucoma successfully but are not capable of indicating an imbalance in flow rates or an
increase in resistance to the outflow of fluid in the eye.
3.  PRESSURE SENSOR ANALYSIS
In developing an integrated system, capable of comprehensively monitoring glaucoma, an analysis was performed on the
pressures that occur in the anterior chamber of the eye. The range of pressures that would be encountered by a
microstructure if it were to be place in a section of the anterior chamber, was, considered for this analysis. The range and
pattern of the stresses that these pressures would create in a microstructure were calculated.  A sensing technology such
as the piezo resistive sensing technology was then applied to determine the sensitivities that could be obtained from these
pressures. The magnitude and range of stresses, which the normal and glaucoma pressures will impart on a
microstructure, are presented in this section. The theoretical calculations were supported with finite element method
(FEM) software (ANSYS) to visualise the stress contours, and compute the regions of maximum stress. A microstructure
having dimensions 2*2*0.001 mm was considered for the pressure analysis.
  3.1 Stresses
ANSYS, a  finite element method (FEM) software, was used to calculate the longitudinal and transverse stresses on the
surface of a microstructure. A 10 node, 3 dimensional solid FEM model was used for the analysis, which provided very
accurate results. The results were found to be consistent with the theoretical calculations in 15. The pressures were applied
as loads, along the (-z)-axis of the microstructure.  The simulations showed that the stresses were maximum at the edge
centres and minimum at the centre of the plate. The stress components along the x and y axes of the microstructure,
between its centre (0, 0), see fig.5, and the edges of the diaphragm were then calculated for the entire range of pressures.
The stresses obtained were, symmetrical on both the perpendicular, axes.
                                    Fig.5 Microstructure with centre (0, 0), and direction of load application.
Fig 6 depicts the stress contours obtained on a microstructure when subjected to IOP loads. The stresses varied uniformly
across the entire surface of the structure.
               Here, σxx       =   Longitudinal Stress,   and   σyy        = Transverse Stress.
A half of the surface, from the centre (0,0) to the edge, of the microstructure was considered along both, x and y
directions, to charchterise the stress pattern. Several nodes were picked at equal intervals, along  both
(y)
(z) (x)
          (0 ,0)
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axes (x,y)on the surface of the micro structure. Table 3, lists pattern of the transverse and longitudinal stresses on the
surface of a microstructure for and a normal IOP load (15 mmHg/1999 Pa/203.926 kg/m2 ).
                                                            Fig 6: Stress contours obtained for IOP loads
Length (m) σxx (kg/m2) σyy (kg/m2)
.001 0.10984E7 0.11019E7
.0012 0.10007E7 0.10148E7
.0014 0.744E6 0.74163E6
.0016 0.1620E6 0.18738E6
.0018 -0.8525E6 -0.58933E6
.002 -0.22649E7 -0.25228E7
                             Table 3: Stress values along surface of a microstructure, for a normal IOP load
On observing the pattern of the stresses in table 3, it can be seen that the magnitude, of the stresses, increased from
0.10984E7, at the centre up to 0.22649E7 at the edges along both the axes, considered. A similar pattern was obtained
when higher, IOP belonging to the Glaucoma regime were applied as loads. The values of the stresses were similar on
both axes for the entire range of IOP.
σyy
σxx
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Figure 7, shows a linear increase in the magnitude of the maximum longitudinal and transverse stresses, estimated to be
obtained along the edge centres of a microstructure, subjected to IOP. The values were calculated from formulas 1 and 2
given in 16 .
.                                     
0.00
5000000.00
10000000.00
15000000.00
20000000.00
25000000.00
30000000.00
204 272 340 408 476 544 612 680
Pressure (kg/m2)  
St
re
ss
  
 
(k
g/
m
2 )
Txx Tyy
                                                                             Fig 7: σxx max = Txx & σyy max = Tyy    for  IOP
3.2 Piezo Resistive Sensing
The piezo resistive theory, for pressure sensing could be applied to estimate the range of output voltages that could be
obtained from normal and glaucomatous, IOP.  In order to do this the regions that depicted maximum stress on the
surface on application of the pressure loads were calculated theoretically using the formulas 1 and 2, provided by Bao 16.
The values obtained were similar to the values obtained from ANSYS simulations in the previous section.                        
                                           
2)/(**02.1max hapxx =σ                                                                               (1)
                                   
2)/(***02.1max hapyy νσ =                                                                           (2)
 The regions that showed maximum stress due to the loads applied would be chosen for the location of resistors. The
differential movement of the resistors, in the longitudinal and transverse, on being subjected to loads would yield in an
output voltage that could be used to detect the pressures that caused them. Thus it would be possible to estimate the
range of electrical outputs that could be obtained from the intra ocular pressures. The symbols used for the calculations
are as follows,
                                     ∆R/R)l      =   Piezo resistance   perpendicular to edge of diaphragm
                                   (∆R/R)t      =    Piezo resistance parallel to the edge of diaphragm
                                     σxx   max      =       Maximum edge centre stresses along x axis
                                     σ
 yy   max      =   Maximum edge centre stresses along y axis
                         ∏44  is a function of the doping level of the resistors, assumed to be = 81.574 x10-12 kg/m2
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The piezo resistors were chosen to be perpendicular to 2 of the edges and parallel to the other 2 edges of the micro
structure, in the regions which showed maximum stress. They were assumed to be in the <110 plane>. The resistors
would have to be located where; the differential movement in the longitudinal and transverse directions would be equal.
                                                tRRlRR )/()/( ∆=∆                                                                                           (3)
The formulas used to calculate the piezo resistive coefficients for the resistors that would be positioned perpendicular to
2 of the edges was, given by formula 4 in 16
                                          )1(*)/(**02.1**5.0)/( 244 ν−Π=∆ haplRR                                                            (4)
A similar formula (5) 16 was used to compute the piezo resistive coefficients for the resistors that would be positioned
parallel to the other 2 edges of the microstructure.
                                      )1(*)/(**02.1**5.0)/( 244 ν−Π−=∆ haptRR                                                            (5)
Table 4, lists the values of the piezo resistive coefficients for the resistors located near the edge centres of a
microstructure, subjected to IOP.
Pressure
(mmHg)
Pressure (kg/m2) (∆R/R) l (∆R/R) t
15 203.926 0.000244337 -0.00024434
20 271.902 0.000325782 -0.00032578
25 339.877 0.000407227 -0.00040723
30 407.853 0.000488673 -0.00048867
35 475.828 0.000570118 -0.00057012
40 543.804 0.000651564 -0.00065156
45 611.779 0.000733009 -0.00073301
50 679.755 0.000814455 -0.00081445
                                           Table 4 Piezo resistive coefficients that will be obtained for IOP loads
 Thus the piezo resistive coefficients for the resistors, that would be placed parallel and perpendicular to the edges of the
microstructure, when subjected to all the IOP, were calculated.  The values were similar to one another but differed in
magnitude owing to the difference in orientation of the resistors.
3.3 Sensitivities
 The sensitivity of a Wheatstone bridge was then calculated for the range of intra ocular pressure that will be encountered
inside the anterior chamber of the eye. The output voltages that would be obtained as a result of the stresses created by
the pressures were calculated using   formula 6 16.
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                                     sout VhapV **)/(**)1(*51.0 442 Π−= ν                                                                 (6)
            Where,
                                 ∏44 is a function of the doping level of the resistors, assumed to be = 81.574x10-12 kg/m2
                                     p = Range of intra ocular pressures applied (203.926kg/m2 - 679.7550 kg/m2
                                    a = 0.002m
                                    h = 0.00001m and
                                    ν = Poisson’s ratio = 0.28 for Si.
                                    Vs = assumed to be 5 volts.
                                                         Table5. Estimated output voltages for IOP
The IOP, inside the anterior chamber of the eye, would yield output voltages between 1 mV and 4 mV if piezo resistors
were embedded onto a microstructure. The output voltages could be linearly increased, by functionalising the
microstructure, to be more sensitive to the intra ocular pressures.
4. CONCLUSION
 The initial efforts towards the development of  a miniature, implantable glaucoma indicator, have been presented. The
piezo resistive pressure sensing mechanism yielded output voltages between 1mV and 4mV, to detect IOP on a
microstructure to be placed in the anterior chamber of the eye. The next step in the research will focus on developing a
mechanism to indicate a shift in the complex flow-pressure equilibrium in the eye to monitor glaucoma conditions. The
practical issues concerning the powering and fabrication of such a device will also be analysed. The development of a
device with these capabilities will indicate to a patient, any changes in the condition of glaucoma and enable him/her to
take steps towards better management of the disease.
Pressure
(mmHg)
Pressure (kg/m2) dV/V
(mV/V)
15 203.926 0.00122
20 271.902 0.00163
25 339.877 0.00204
30 407.853 0.00244
35 475.828 0.00285
40 543.804 0.00326
45 611.779 0.00367
50 679.755 0.00407
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